About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
976 genotypes with 1347 annotations displayed of selected term and subterms
Searched Term: seizures
Allelic Composition
(Genetic Background)		 Annotated Term Reference
\2310061I04Rikm1Ifd/\2310061I04Rikm1Ifd
\Traf7tm1.1Ifd/\Traf7tm1.1Ifd
(involves: C57BL/6N) 		seizures J:360757
\Achetm4Pata/\Achetm4Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB) 		seizures J:147855
\Acp2tm1Psa/\Acp2tm1Psa
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J) 		tonic-clonic seizures J:41986
\Adam22tm1Sag/\Adam22tm1Sag
(either: B6.Cg-Adam22tm1Sag or (involves: C57BL/6 * C57BL/6N * CBA)) 		convulsive seizures J:99692
\Adamts4tm1Dgen/\Adamts4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Adarb1tm1Phs/\Adarb1tm1Phs
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:63273
\Adgrv1frings/\Adgrv1frings
(RB/1) 		audiogenic seizures J:25341
\Adgrv1frings/\Adgrv1frings
(BUB/BnJ) 		audiogenic seizures J:97534
\Adgrv1tm1Msat/\Adgrv1tm1Msat
(involves: 129P2/OlaHsd * C57BL/6J) 		audiogenic seizures J:95518
\Adgrv1tm1Msat/\Adgrv1tm1Msat
(B6.129P2-Adgrv1tm1Msat) 		audiogenic seizures J:95518
\Adgrv1tm1Pwh/\Adgrv1tm1Pwh
(involves: 129S1/Sv * C57BL/6J) 		audiogenic seizures J:90899
\Adktm2Bois/\Adktm2Bois
\Adora1tm1Bbf/\Adora1tm1Bbf
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		environmentally induced seizures J:237189
\Adktm2Bois/\Adktm2Bois
\Adora2atm1Jfc/\Adora2atm1Jfc
\Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased susceptibility to induction of seizure by inducing agent J:237189
\Adktm2Bois/\Adktm2Bois
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		convulsive seizures J:237189
environmentally induced seizures J:237189
increased susceptibility to pharmacologically induced seizures J:237189
\Adora2btm1.1(KOMP)Vlcg/\Adora2b+
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
\Adra2atm1Bkk/\Adra2atm1Bkk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal spike wave discharge J:197965
\Agpat1tm1Garg/\Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6) 		audiogenic seizures J:250301
\Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
\Aifm1Hq/\Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
\Akap5tm1.1Jsco/\Akap5tm1.1Jsco
(involves: 129S * C57BL/6 * FVB/N) 		decreased susceptibility to pharmacologically induced seizures J:138972
\Akt3Nmf350/\Akt3+
(C57BL/6J-Akt3Nmf350) 		abnormal seizure response to electrical stimulation J:169028
increased susceptibility to pharmacologically induced seizures J:169028
maximal tonic hindlimb extension seizures J:169028
sporadic seizures J:169028
tonic-clonic seizures J:169028
\Akt3Nmf350/\Akt3Nmf350
(C57BL/6J-Akt3Nmf350) 		abnormal seizure response to electrical stimulation J:169028
increased susceptibility to pharmacologically induced seizures J:169028
maximal tonic hindlimb extension seizures J:169028
tonic-clonic seizures J:169028
\Akt3tm1Mbb/\Akt3tm1Mbb
(involves: C57BL/6J) 		abnormal seizure response to electrical stimulation J:169028
maximal tonic hindlimb extension seizures J:169028
tonic-clonic seizures J:169028
\Aldh5a1tm1Kmg/\Aldh5a1tm1Kmg
(involves: 129/Sv * C57BL/6) 		absence seizures J:91856
myoclonus J:71949
tonic seizures J:71949
\Aldh7a1tm1d(EUCOMM)Hmgu/\Aldh7a1tm1d(EUCOMM)Hmgu
(B6(FVB)-Aldh7a1tm1d(EUCOMM)Hmgu) 		seizures J:298561
\Aldh7a1tm1d(EUCOMM)Hmgu/\Aldh7a1tm1d(EUCOMM)Hmgu
(129S1.B6N(FVB)-Aldh7a1tm1d(EUCOMM)Hmgu) 		seizures J:298561
\Alg13em1Bayu/Y
(involves: C57BL/6J) 		environmentally induced seizures J:275180
increased susceptibility to pharmacologically induced seizures J:275180
\Alpltm1Jlm/\Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J)) 		seizures J:39015
\Alpltm1Sor/\Alpltm1Sor
(either: (involves: 129S7/SvEvBrd-Alpltm1Sor) or (involves: 129S7/SvEvBrd * C57BL/6)) 		seizures J:28394
\Amphtm1Pdc/\Amphtm1Pdc
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:75306
tonic seizures J:75306
\Ank3tm1Bnt/\Ank3tm1Bnt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:51377
\Ano3tm1.1Lyj/\Ano3tm1.1Lyj
\Ptgdstm1.1(cre)Gvn/\Ptgds+
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		environmentally induced seizures J:310618
\Ano3tm1.1Lyj/\Ano3tm1.1Lyj
\Tg(Nes-cre)1Kln/0
(involves: 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:310618
\Ap3b2m1J/\Ap3b2m1J
(C57BL/6J-Ap3b2m1J/FrkJ) 		tonic-clonic seizures J:205908
\Ap3b2m2J/\Ap3b2m2J
(B6;129S-Ap3b2m2J/GrsrJ) 		tonic-clonic seizures J:222308, J:205908
\Ap3b2tm1Bur/\Ap3b2tm1Bur
(C57BL/6-Ap3b2tm1Bur) 		tonic-clonic seizures J:94942
\Ap3d1mh-2J/\Ap3d1mh-2J
(involves: C3H/HeJ * C57BL/6J * CAST/Ei) 		abnormal spike wave discharge J:59842
\Ap3d1mh/\Ap3d1mh
(STOCK Mfsd12gr +/+ Ap3d1mh/J) 		abnormal spike wave discharge J:59842
\Ap3m2tm1Ohno/\Ap3m2tm1Ohno
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal kindling response J:93312
increased susceptibility to pharmacologically induced seizures J:93312
nonconvulsive seizures J:93312
seizures J:93312
\Apc2tm1Mno/\Apc2tm1Mno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:184856
\Apoetm1Unc/\Apoetm1Unc
(B6.129P2-Apoetm1Unc) 		abnormal kindling response J:118390
\Arf4tm1.1Tsdk/\Arf4+
\Arf5tm1.1Tsdk/\Arf5tm1.1Tsdk
(B6J.B6N-Arf4tm1.1Tsdk Arf5tm1.1Tsdk) 		abnormal spike wave discharge J:279779
\Arhgap32tm1Taki/\Arhgap32tm1Taki
(B6N.Cg-Arhgap32tm1Taki) 		increased susceptibility to pharmacologically induced seizures J:236753
\Arhgef9em1Frk/Y
(C57BL/6NJ-Arhgef9em1Frk/FrkJ) 		absence seizures J:364541
myoclonus J:364541
seizures J:364541
tonic seizures J:364541
tonic-clonic seizures J:364541
\Arv1tm1.2Geno/\Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J) 		seizures J:263695
\Arxtm1.1Jno/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		clonic seizures J:151082
myoclonus J:151082
seizures J:151082
tonic-clonic seizures J:151082
\Arxtm1.1Jno/\Arxtm1.1Jno
(involves: 129S7/SvEvBrd * C57BL/6J) 		myoclonus J:151082
\Arxtm1Gldn/Y
\Tg(mI56i-cre,-EGFP)1Kc/0
(involves: 129/Sv * C57BL/6 * CD-1 * FVB/N) 		clonic seizures J:148311
sporadic seizures J:148311
tonic-clonic seizures J:148311
\Arxtm1Gldn/\Arx+
\Tg(mI56i-cre,-EGFP)1Kc/0
(involves: 129/Sv * C57BL/6 * CD-1 * FVB/N) 		clonic seizures J:148311
convulsive seizures J:148311
sporadic seizures J:148311
tonic-clonic seizures J:148311
\Arxtm3Kki/Y
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:152416
\Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6J) 		abnormal spike wave discharge J:152416
seizures J:152416
tonic seizures J:152416
\Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd) 		myoclonus J:260340
\Arxtm5Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd) 		myoclonus J:260340
seizures J:260340
\Asnsd1Gt(OST460318)Lex/\Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		environmentally induced seizures J:320329
\Asp1/\Asp1
(DBA/2J) 		audiogenic seizures J:6355
\Asp2/\Asp2
(DBA/2J) 		audiogenic seizures J:11261, J:5094
\Asp3DBA/2J/\Asp3DBA/2J
(DBA/2J) 		audiogenic seizures J:11261
\Aspanur7/\Aspanur7
(involves: C57BL/6J) 		seizures J:143201, J:226682
\Atad1tm1.1Vdaw/\Atad1tm1.1Vdaw
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		seizures J:173768
\Atad1tm1Vdaw/\Atad1tm1Vdaw
\Tg(Camk2a-cre)2Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		seizures J:173768
\Atcayji/\Atcayji
(Not Specified) 		seizures J:14903
\Ate1tm1Avar/\Ate1tm2.1Avar
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		seizures J:155421
tonic-clonic seizures J:155421
\Atox1Gt(IRESBetageo)3Pgr/\Atox1Gt(IRESBetageo)3Pgr
(B6.129(Cg)-Atox1Gt(IRESBetageo)3Pgr/Mmucd) 		seizures J:74249
\Atp1a3Myk/\Atp1a3+
(B6NCr.129S1-Atp1a3Myk) 		abnormal seizure response to inducing agent J:180250
abnormal spike wave discharge J:151948
convulsive seizures J:151948
environmentally induced seizures J:151948
\Atp1a3Myk/\Atp1a3+
(involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr) 		abnormal spike wave discharge J:151948
convulsive seizures J:151948
environmentally induced seizures J:151948
\Atp1a3tm1.1Tmklh/\Atp1a3+
(B6JRj.129S1-Atp1a3tm1.1Tmklh) 		increased susceptibility to pharmacologically induced seizures J:254463
\Atp1a3tm1Mika/\Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal seizure response to inducing agent J:264408
increased kindling response J:264408
seizures J:264408
\Atp1a3tm1Ute/\Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased kindling response J:262419
increased susceptibility to pharmacologically induced seizures J:262419
seizures J:262419
\Atp6v1b2em1Pcamp/\Atp6v1b2+
(C57BL/6N-Atp6v1b2em1Pcamp) 		increased susceptibility to pharmacologically induced seizures J:342781
\Atp6v1b2em1Pcamp/\Atp6v1b2em1Pcamp
(C57BL/6N-Atp6v1b2em1Pcamp) 		environmentally induced seizures J:342781
increased susceptibility to pharmacologically induced seizures J:342781
\Atp6v1b2tm1Yoyu/\Atp6v1b2tm1Yoyu
(involves: C57BL/6) 		environmentally induced seizures J:278514
\Atp7aMo-ml/Y
(C3Hf/He) 		tonic seizures J:40664
\Atrnmg-3J/\Atrnmg-3J
(C3HeB/FeJ-Atrnmg-3J/J) 		seizures J:96070
\Atxn7tm1Hzo/\Atxn7+
(involves: 129S7/SvEvBrd * C57BL/6) 		myoclonus J:82072
\Avpr1btm1Dgen/\Avpr1btm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\B4galnt1tm1Rlp/\B4galnt1tm1Rlp
\St8sia1tm1Rlp/\St8sia1tm1Rlp
(involves: 129S6/SvEvTac) 		audiogenic seizures J:67955
seizures J:67955
tonic-clonic seizures J:67955
\Baiap3tm1Smwk/\Baiap3tm1Smwk
(B6N.129P2-Baiap3tm1Smwk) 		increased susceptibility to pharmacologically induced seizures J:221234
\Bak1tm1Thsn/\Bak1tm1Thsn
\Baxtm1Sjk/\Baxtm1Sjk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6) 		seizures J:66872
\BckdkGt(VICT48)710Lex/\BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex) 		seizures J:117564
tonic-clonic seizures J:117564
\Bdnftm3Jae/\Bdnftm3Jae
\Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		abnormal kindling response J:91467
\Bhlhe40tm1.1Rhli/\Bhlhe40tm1.1Rhli
(involves: 129S1/Sv * C57BL/6 * CD-1 * SJL) 		increased susceptibility to pharmacologically induced seizures J:131834
\Bidtm1Sjk/\Bidtm1Sjk
\Cstbtm1Rm/\Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		myoclonus J:115694
seizures J:115694
\Bis1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
\Bis4A/J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
\Bloc1s6pa/\Bloc1s6pa
(B6.Cg-Bloc1s6pa/J) 		tonic seizures J:5215
\Bmi1tm1Brn/\Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB)) 		sporadic seizures J:17712
\Braftm1Bbd/\Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1) 		convulsive seizures J:170095
\Bsntm1Gund/\Bsntm1Gund
(Not Specified) 		clonic seizures J:82241
convulsive seizures J:82241
increased susceptibility to pharmacologically induced seizures J:82241
myoclonus J:82241
\C1qatm1Mjw/\C1qatm1Mjw
(involves: 129S/SvEv) 		absence seizures J:159281
seizures J:159281
\Cacna1arkr/\Cacna1arkr
(B6.Cg-Cacna1arkr) 		absence seizures J:71860
\Cacna1atg-4J/\Cacna1atg-4J
(B6.C3Bir-Cacna1atg-4J) 		absence seizures J:137816
\Cacna1atg/\Cacna1atg
(B6.D2-Cacna1atg/J) 		increased susceptibility to pharmacologically induced seizures J:6154
seizures J:6154
\Cacna1atg/\Cacna1atg
(involves: 101 * C3H * C57BL/10 * DBA/2J) 		seizures J:262
sporadic seizures J:262
\Cacna1atm1.1Sher/\Cacna1atm1.1Sher
\Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		abnormal seizure response to inducing agent J:170451
abnormal spike wave discharge J:170451
absence seizures J:170451
environmentally induced seizures J:170451
\Cacna1atm1.2Sher/\Cacna1atm1.2Sher
(involves: 129S4/SvJae) 		seizures J:170451
\Cacna1atm1Hssh/\Cacna1atm1Hssh
(involves: C57BL/6J) 		abnormal spike wave discharge J:59076
\Cacna1atm1Lory/\Cacna1a+
(involves: C57BL/6 * C57BL/6J) 		absence seizures J:258570
\Cacna1atm1Nobs/\Cacna1atm2Nobs
(involves: 129 * C57BL/6J) 		absence seizures J:155607
\Cacna1atm2Nobs/\Cacna1atm2Nobs
(involves: 129 * C57BL/6J) 		abnormal spike wave discharge J:155607
absence seizures J:155607
clonic seizures J:155607
\Cacna1atm3Maag/\Cacna1atm3Maag
(B6.129P2-Cacna1atm3Maag) 		seizures J:144701
\Cacna1gtm1Hssh/\Cacna1gtm1Hssh
(involves: 129S4/SvJae * C57BL/6J) 		abnormal spike wave discharge J:70557
decreased susceptibility to pharmacologically induced seizures J:70557
\Cacna2d2du-2J/\Cacna2d2du-2J
(involves: C57BLKS/J-Cacna2d2du-2J/LetJ) 		abnormal spike wave discharge J:70845
absence seizures J:70845
\Cacna2d2du-2J/\Cacna2d2du-2J
(involves: C57BL/6 * C57BLKS/J) 		absence seizures J:213548
\Cacna2d2du-3J/\Cacna2d2du-3J
(involves: BALB/cByJ * C57BL/6J) 		myoclonus J:82238
\Cacna2d2du/\Cacna2d2du
(TKDU/DnJ) 		seizures J:5263
\Cacna2d2du/\Cacna2d2du
(TKDU) 		seizures J:152373
\Cacna2d2ent/\Cacna2d2ent
(either: B6.D2-Cacna2d2ent or (involves: C57BL/6J * CD-1 * DBA/2J)) 		seizures J:88967
\Cacna2d2tm1Svi/\Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:92396
myoclonus J:92396
seizures J:92396
tonic seizures J:92396
\Cacnb4lh-2J/\Cacnb4lh-2J
(involves: C3H * C57BL/6 * DBA/2J) 		seizures J:137891
\Cacnb4lh/\Cacnb4lh
(involves: BALB/cGn * C3H/HeSnJ * C57BL/6JEi) 		clonic seizures J:79139
seizures J:1484
tonic seizures J:79139
\Cacnb4lh/\Cacnb4lh
(involves: BALB/cGn) 		convulsive seizures J:28466
\Cacng2stg-3J/\Cacng2+
\Cacng4tm1Frk/\Cacng4+
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
\Cacng2stg-3J/\Cacng2stg-3J
\Cacng4tm1Frk/\Cacng4+
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
\Cacng2stg-3J/\Cacng2stg-3J
\Cacng4tm1Frk/\Cacng4tm1Frk
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
\Cacng2stg-wag/\Cacng2stg-wag
(B6.MRL-Cacng2stg-wag/J) 		absence seizures J:96506
\Cacng2stg-wag/\Cacng2stg-wag
\Cacng4tm1Frk/\Cacng4tm1Frk
(involves: B6.MRL-Cacng2stg-wag/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
\Cacng2stg/\Cacng2stg
(B6C3Fe a/a-Cacng2stg) 		absence seizures J:15527
\Camk2atm1.1Oyam/\Camk2a+
(either: B6.Cg-Camk2atm1.1Oyam or (involves: C57BL/6 * CBA * ICR)) 		sporadic seizures J:150046
\Camk2atm1.1Oyam/\Camk2atm1.1Oyam
(either: B6.Cg-Camk2atm1.1Oyam or (involves: C57BL/6 * CBA * ICR)) 		sporadic seizures J:150046
\Camk2atm4Sva/\Camk2atm4Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac) 		seizures J:79714
\Camk2atm5Sva/\Camk2atm5Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac) 		seizures J:79714
\Camsap1tm1Wem/\Camsap1tm1Wem
(involves: C57BL/6J) 		seizures J:296029
\Car7tm1.1Kkai/\Car7tm1.1Kkai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:200079
\Ccm2tm2.1Sbn/\Ccm2tm2.1Sbn
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		seizures J:174085
\Cd3em1Btlr/\Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr) 		seizures J:132486
\Cdk5r1tm1Lht/\Cdk5r1tm1Lht
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38857
seizures J:38857
\Cdk5r1tm1Lht/\Cdk5r1tm1Lht
(involves: 129S4/SvJae) 		seizures J:38857
\Cdkl5tm1.2Cogr/Y
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J) 		abnormal seizure response to inducing agent J:209635
seizures J:209635
\Cdkl5tm1.2Cogr/\Cdkl5tm1.2Cogr
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J) 		abnormal seizure response to inducing agent J:209635
seizures J:209635
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Cdkn2dtm1Maro/\Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6) 		seizures J:58522
\Cdkn2atm1Nesh/\Cdkn2atm1Nesh
(involves: 129S6/SvEvTac * FVB/N) 		seizures J:88365
\Cdyltm1.1Yuw/\Cdyltm1.1Yuw
\Emx1tm1(cre)Yql/\Emx1+
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:251551
\Celf4Ff/\Celf4+
(involves: C57BL/6J) 		abnormal seizure response to electrical stimulation J:123744
seizures J:123744
\Celf4Ff/\Celf4Ff
(involves: C57BL/6J) 		tonic-clonic seizures J:123744
\Celf4Ff/\Celf4Ff
(involves: C57BL/6J * FVB/NJ) 		absence seizures J:123744
\Celf4tm1.1Frk/\Celf4tm1.1Frk
\Emx1tm1(cre)Krj/?
(involves: 129 * C57BL/6J) 		increased susceptibility to induction of seizure by inducing agent J:19671
\Celf4tm1.1Frk/\Celf4tm1.1Frk
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6J) 		abnormal spike wave discharge J:181678
convulsive seizures J:181678
\Celf4tm1.1Frk/\Celf4tm1.1Frk
\Tg(Camk2a-cre)1Lfr/0
(involves: 129 * C57BL/6J) 		increased susceptibility to induction of seizure by inducing agent J:194671
\Celf4tm1.1Frk/\Celf4tm1.1Frk
\Tg(Slc32a1-cre)2.1Hzo/0
(involves: 129 * C57BL/6J * FVB) 		decreased susceptibility to induction of seizure by inducing agent J:194671
\Celf4tm1.2Frk/\Celf4+
(129S1.129(Cg)-Celf4tm1.2Frk/Frk) 		tonic-clonic seizures J:181678
\Celf4tm1.2Frk/\Celf4tm1.2Frk
(129S1.129(Cg)-Celf4tm1.2Frk/Frk) 		abnormal spike wave discharge J:181678
absence seizures J:181678
seizures J:181678
tonic-clonic seizures J:181678
\Celf4tm1.2Frk/\Celf4tm1.2Frk
((B6.129(Cg)-Celf4tm1.2Frk/Frk x 129S1.129(Cg)-Celf4tm1.2Frk/Frk)F1) 		abnormal spike wave discharge J:181678
absence seizures J:181678
\Celf4tm1.2Frk/\Celf4tm1.2Frk
(B6.129(Cg)-Celf4tm1.2Frk/Frk) 		seizures J:181678
tonic-clonic seizures J:181678
\Cers1to/\Cers1to
(either: FVB/N or (involves: C3H * C57BL/6J * FVB/N)) 		seizures J:91243
\Cfl1tm1.1Wit/\Cfl1tm1.1Wit
(involves: 129 * C57BL/6 * SJL) 		seizures J:125317
\cg/\cg
(involves: C57BL/6Ga) 		tonic-clonic seizures J:11941
\Chn1tm1.1Abet/\Chn1tm1.1Abet
(involves: 129P2/OlaHsd * FVB/N) 		tonic seizures J:128724
\Chn1tm2Abet/\Chn1tm2Abet
(involves: 129P2/OlaHsd * FVB/N) 		tonic seizures J:128724
\Chrna4tm1Dra/\Chrna4tm1Dra
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:97020
\Chrna4tm1Jbou/\Chrna4+
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
\Chrna4tm1Jbou/\Chrna4tm1Jbou
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
\Chrna4tm2Jbou/\Chrna4+
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
\Chrna4tm2Jbou/\Chrna4tm2Jbou
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
\Chrna5tm1Mdb/\Chrna5tm1Mdb
(B6.129-Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
\Chrna5tm1Mdb/\Chrna5tm1Mdb
\Chrnb4tm1Mdb/\Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
\Chrna7tm1Bay/\Chrna7tm1Bay
(B6.Cg-Chrna7tm1Bay) 		abnormal seizure response to pharmacological agent J:74703
\Chrnb2tm1.1Cont/\Chrnb2+
(B6.129-Chrnb2tm1.1Cont) 		increased susceptibility to induction of seizure by inducing agent J:228269
\Chrnb2tm1.1Cont/\Chrnb2tm1.1Cont
(B6.129-Chrnb2tm1.1Cont) 		increased susceptibility to induction of seizure by inducing agent J:228269
\Chrnb4tm1Mdb/\Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
\Cittm1Fdc/\Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased susceptibility to pharmacologically induced seizures J:77297
myoclonus J:77297
\Ckbtm1Bew/\Ckbtm1Bew
(involves: 129P/Ola * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:89399
\Clcn3tm1Lamb/\Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:80901
seizures J:80901
tonic-clonic seizures J:80901
\Clcn7tm1.1Lex/\Clcn7tm1.1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		tonic seizures J:186049
\Cln3tm1Blda/\Cln3tm1Blda
(B6.129-Cln3tm1Blda) 		increased susceptibility to pharmacologically induced seizures J:125194
\Cln6nclf/\Cln6nclf
(involves: C57BL/6J * C57BL/10J * C3HeB/FeJLe) 		seizures J:47292
\Cln8mnd/\Cln8mnd
(involves: B6.KB2) 		seizures J:47292
\Cnptm1(cre)Kan/\Cnptm1(cre)Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:91814
\Cnr1tm1.1Ltz/\Cnr1+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
\Cnr1tm1.1Ltz/\Cnr1tm1.1Ltz
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
\Cnr1tm1.2Ltz/\Cnr1tm1.2Ltz
(involves: 129P2/OlaHsd * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
\Cnr1tm1.2Ltz/\Cnr1tm1.2Ltz
\Neurod6tm1(cre)Kan/\Neurod6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
\Cnr1tm1.2Ltz/\Cnr1tm1.2Ltz
\Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
\Cnr1tm1.2Ltz/\Cnr1tm1.2Ltz
\Tg(Camk2a-cre)2Gsc/?
(involves: 129P2/OlaHsd * C57BL/6NCrl * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:122066
\Cnr1tm2Ltz/\Cnr1tm2Ltz
(B6.Cg-Cnr1tm2Ltz) 		increased susceptibility to pharmacologically induced seizures J:199647
\Cntn2tm1Fuka/\Cntn2tm1Fuka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:67556
sporadic seizures J:67556
\Cntn5tm1Kwat/\Cntn5tm1Kwat
(involves: 129X1/SvJ * C57BL/6J) 		audiogenic seizures J:89425
\Cntnap2tm1Pele/\Cntnap2tm1Pele
(B6.129-Cntnap2tm1Pele) 		environmentally induced seizures J:177110
seizures J:177110
\Cntnap4tm1Pele/\Cntnap4tm1Pele
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		seizures J:211338
\Col1a1tm3(CAG-IDH2*R140Q)Kkw/\Col1a1+
\Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N) 		seizures J:209629
\Col2a1sedc/\Col2a1sedc
(involves: C57BL/6J) 		seizures J:85735
\Col4a1deltaex40/\Col4a1+
(B6.129S-Col4a1deltaex40) 		seizures J:215446
\Coq8atm1.1Ics/\Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N) 		environmentally induced seizures J:249129
increased susceptibility to pharmacologically induced seizures J:249129
\Cosz1DBA/2J/\Cosz1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
\Cosz2DBA/2J/\Cosz2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
\Cosz3C57BL/6J/\Cosz3C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
\Cosz3C57BL/6J/\Cosz3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
\Cplx1tm2Bros/\Cplx1tm2Bros
(Not Specified) 		sporadic seizures J:86365
\CrebbpGt(U-San)112Imeg/\Crebbp+
(involves: C57BL/6 * CBA) 		seizures J:53370
\Cremtm1.1Endo/\Cremtm1.1Endo
(C57BL/6-Cremtm1.1Endo) 		abnormal kindling response J:137666
\cri/\cri
(involves: DBA/2J) 		clonic seizures J:6110
\Cstbtm1Rm/\Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		myoclonus J:50587
\Cstbtm1Rm/\Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		myoclonus J:115694
seizures J:115694
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem
\Emx1tm1(cre)Yql/\Emx1+
(B6.129-Emx1tm1(cre)Yql Ctnnb1tm2Kem) 		increased susceptibility to pharmacologically induced seizures J:92923
seizures J:92923
\Ctsdtm1Cptr/\Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd)) 		seizures J:64892, J:71688
tonic seizures J:64892
\Cul4btm1Swl/Y
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(B6.Cg-Edil3Tg(Sox2-cre)1Amc Cul4btm1Swl) 		increased susceptibility to pharmacologically induced seizures J:187403
\Cyb5d1tm1.1(KOMP)Vlcg/\Cyb5d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cyb5d1tm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
\Dbnltm1Jwnd/\Dbnl+
(involves: BALB/c) 		convulsive seizures J:109363
\Dbptm1Schb/\Dbptm1Schb
\Hlftm1Schb/\Hlftm1Schb
\Teftm1Schb/\Tef+
(involves: 129P2/OlaHsd * 129S2/SvPas) 		absence seizures J:90854
seizures J:90854
\Dbptm1Schb/\Dbptm1Schb
\Hlftm1Schb/\Hlftm1Schb
\Teftm1Schb/\Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas) 		absence seizures J:90854
audiogenic seizures J:90854
seizures J:90854
tonic-clonic seizures J:90854
\Dclk2tm1.2Jgg/\Dclk2tm1.2Jgg
\Dcxtm1Caw/Y
(involves: 129/Sv * C57BL/6) 		convulsive seizures J:148345
tonic-clonic seizures J:148345
\Dclk2tm1.2Jgg/\Dclk2tm1.2Jgg
\Dcxtm1Caw/\Dcxtm1Caw
(involves: 129/Sv * C57BL/6) 		convulsive seizures J:148345
tonic-clonic seizures J:148345
\Del(5D5Mit73-D5Mit351)5Jcs/\+
(involves: 129S4/SvJae * C57BL/6J) 		maximal tonic hindlimb extension seizures J:67077
seizures J:67077
\Del(5D5Mit388-D5Mit351)4Jcs/\+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal seizure response to electrical stimulation J:67077
\Del(5Letm1-D5Mit81)3Jcs/\+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal seizure response to electrical stimulation J:67077
\Del(5Letm1-Htt)1Jcs/\+
(involves: 129S4/SvJae * C57BL/6J) 		convulsive seizures J:67077
\Del(7Chrna7-Fan1)3Arte/\+
(involves: C57BL/6J * C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:260165
abnormal seizure response to pharmacological agent J:260165
decreased susceptibility to pharmacologically induced seizures J:260165
\Del(7Gabrb3-Ube3a)1Yhj/\+
(B6.129S7-Del(7Gabrb3-Ube3a)1Yhj) 		tonic-clonic seizures J:164010
\Del(11Cops3-Rnf112)1Jrl/\+
(involves: 129S7/SvEvBrd * C57BL/6) 		seizures J:88027
tonic-clonic seizures J:83302
\Del(XArmcx5-Nxf3)3Jw/\+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		environmentally induced seizures J:210663
\Del(XNxf2-Nxf3)1Jw/\+
(involves: 129S4/SvJae * C57BL/6 * FVB) 		audiogenic seizures J:210663
environmentally induced seizures J:210663
sporadic seizures J:210663
\Depdc5tm1c(EUCOMM)Hmgu/\Depdc5tm1c(EUCOMM)Hmgu
\Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6N * CBA) 		increased susceptibility to pharmacologically induced seizures J:260943
seizures J:260943
tonic seizures J:260943
tonic-clonic seizures J:260943
\DgkdGt(RRT600)Byg/\DgkdGt(RRT600)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:126380
\Dgketm1Ngb/\Dgketm1Ngb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		tonic seizures J:68824
\Dido1tm3Cmar/\Dido1tm3.1Cmar
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
(involves: 129S/SvEv * C57BL/6) 		seizures J:328215
\Dmtf1tm1Cjs/\Dmtf1tm1Cjs
(involves: 129/Sv * C57BL/6) 		seizures J:63444
\Dnm1Ftfl/\Dnm1+
(C57BL/6J-Dnm1Ftfl) 		abnormal kindling response J:163311
abnormal seizure response to electrical stimulation J:163311
tonic seizures J:163311
\Dnm1Ftfl/\Dnm1+
(FVB.B6-Dnm1Ftfl/Frk) 		seizures J:235711
\Dnm1Ftfl/\Dnm1Ftfl
(C57BL/6J-Dnm1Ftfl) 		convulsive seizures J:163311
tonic-clonic seizures J:163311
\Dnm1Ftfl/\Dnm1tm1.2Frk
(involves: 129 * C57BL/6J * FVB) 		seizures J:235711
\Dnm1Ftfl/\Dnm1tm2.2Frk
(involves: 129 * C57BL/6J * FVB) 		seizures J:235711
\Dnmt3atm1b(KOMP)Wtsi/\Dnmt3a+
(C57BL/6N-Dnmt3atm1b(KOMP)Wtsi/J) 		convulsive seizures J:211773
\Drd1tm2Jcd/\Drd1+
\Tg(Camk2a-cre)2Gsc/0
(involves: 129S4/SvJae * FVB/N) 		seizures J:120070
\Drd1tm2Jcd/\Drd1+
\Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S4/SvJae * BALB/c * CD-1 * FVB/N) 		myoclonus J:120582
\Drd2tm1Ebo/\Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:65767
\Dscamdel17/\Dscamdel17
(involves: BALB/cByJ * C57BL/6J) 		seizures J:129238
\Dstdt-33J/\Dstdt-33J
(129S1/Sv) 		seizures J:61053
\Dyrk1aem1Kzy/\Dyrk1a+
(C57BL/6J-Dyrk1aem1Kzy) 		environmentally induced seizures J:259596
\Ecpasem1Plch/\Ecpasem1Plch
(C57BL/6-Ecpasem1Plch) 		increased susceptibility to pharmacologically induced seizures J:282974
\Eef1a2em1Abb/\Eef1a2em1Abb
(C57BL/6JCrl-Eef1a2em1Abb) 		sporadic seizures J:296080
\Eef1dtm1.2Mkma/\Eef1dtm1.2Mkma
(B6J.B6N(Cg)-Eef1dtm1.2Mkma) 		audiogenic seizures J:288930
tonic-clonic seizures J:288930
\Efhc1tm1Kzy/\Efhc1+
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
myoclonus J:145858
\Efhc1tm1Kzy/\Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
myoclonus J:145858
\Eif2ak3tm1Dron/\Eif2ak3+
\Tg(GFAP-tTA)110Pop/0
\Tg(tetO-Ifng)184Pop/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * Swiss Webster) 		tonic seizures J:99655
\Eif2b4tm1.1Vdk/\Eif2b4+
\Eif2b5tm1.1Vdk/\Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
\Eif2b4tm1.1Vdk/\Eif2b4tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
\Eif2b4tm1.1Vdk/\Eif2b4tm1.1Vdk
\Eif2b5tm1.1Vdk/\Eif2b5+
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
\Eif2b4tm1.1Vdk/\Eif2b4tm1.1Vdk
\Eif2b5tm1.1Vdk/\Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
\Eif2b5tm1.1Vdk/\Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
\El1EL/?
(involves: DBA/2J * EL) 		seizures J:11381
\El1EL/?
(involves: ABP/LeJ * EL) 		seizures J:11381
\El2EL/?
(involves: ABP/LeJ * EL) 		seizures J:11381
\El2EL/\El2EL
(involves: ABP/LeJ * EL/Suz) 		seizures J:114157
\El3EL/SuzSeyFrkJ/\El3ABP/LeJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:30433
\El3EL/SuzSeyFrkJ/\El3EL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:30433
\El4EL/SuzSeyFrkJ/\El4EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
\El4EL/SuzSeyFrkJ/\El4EL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:114157, J:30433
\El5DDY/Jcl/\El5EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
\El5EL/SuzSeyFrkJ/\El5EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
\El6DDY/Jcl/\El6DDY/Jcl
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
\Elavl3tm1.1Rbd/\Elavl3+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1)) 		abnormal spike wave discharge J:188326
\Elavl3tm1.1Rbd/\Elavl3tm1.1Rbd
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1)) 		abnormal spike wave discharge J:188326
nonconvulsive seizures J:188326
\Elfn1tm1(KOMP)Vlcg/\Elfn1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		seizures J:209758
\Elfn1tm1.1Jaru/\Elfn1tm1.1Jaru
(involves: C57BL/6) 		environmentally induced seizures J:226212
increased susceptibility to pharmacologically induced seizures J:226212
\Elfn2tm1(KOMP)Vlcg/\Elfn2tm1(KOMP)Vlcg
(C57BL/6NTac-Elfn2tm1(KOMP)Vlcg) 		audiogenic seizures J:286127
increased susceptibility to pharmacologically induced seizures J:286127
\ElnvEL/SuzSeyFrkJ/\ElnvEL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:114157
\Elovl4tm1Wked/\Elovl4tm1Wked
\Tg(IVL-Elovl4)#Wked/0
\Tg(KRT14-Elovl4)#Mpag/0
(involves: 129 * C57BL/6) 		seizures J:277065
\Elp1tm1.1Id/\Elp1tm1.2Id
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		audiogenic seizures J:188923
environmentally induced seizures J:188923
\Elp1tm1.2Id/\Elp1tm1.2Id
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		audiogenic seizures J:188923
environmentally induced seizures J:188923
\Eml1heco/\Eml1heco
(involves: NOR) 		increased susceptibility to pharmacologically induced seizures J:208031
myoclonus J:208031
seizures J:208031
\Emx1tm1(cre)Krj/?
\Kcnq2tm1.1Avtz/\Kcnq2tm1.1Avtz
(involves: 129S2/SvPas * C57BL/6) 		tonic-clonic seizures J:208109
\Emx1tm1(cre)Krj/\Emx1+
\Numbtm1Ynj/\Numbtm1Ynj
\Numbltm1Wmz/\Numbltm1Wmz
(involves: 129S2/SvPas * 129X1/SvJ * CD-1) 		sporadic seizures J:87149
\Emx1tm1.1(cre)Ito/\Emx1+
\Scn1atm2.1Kzy/\Scn1atm2.1Kzy
\Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:202863
\Emx1tm1.1(cre)Ito/\Emx1+
\Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
\epf/\epf
(Not Specified) 		seizures J:6309
\Epm2atm1Kzy/\Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J) 		myoclonus J:76688
\Ercc6tm1Gvh/\Ercc6tm1Gvh
\Xpatm1Gvh/\Xpatm1Hvs
\Tg(Camk2a-cre)1Szi/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA) 		seizures J:179808
\Exq1A/J/?
(involves: A/J * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:54925
\Exq1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
\Faim2tm1Dgen/\Faim2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk) 		abnormal seizure response to electrical stimulation J:169028
maximal tonic hindlimb extension seizures J:169028
tonic-clonic seizures J:169028
\Fgf7tm1Efu/\Fgf7tm1Efu
(B6.129-Fgf7tm1Efu) 		increased susceptibility to pharmacologically induced seizures J:161954
\Fgf13tm1Jom/\Fgf13+
(C57BL/6-Fgf13tm1Jom) 		abnormal kindling response J:222555
environmentally induced seizures J:222555
seizures J:222555
\Fgf14tm1Dor/\Fgf14tm1Dor
(129S6/SvEvTac-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
\Fgf14tm1Dor/\Fgf14tm1Dor
(B6.129S6-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
\Fgf22tm1Dgen/\Fgf22tm1Dgen
(B6.Cg-Fgf22tm1Dgen) 		decreased susceptibility to pharmacologically induced seizures J:161954
\Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		audiogenic seizures J:127792
\Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * FVB) 		convulsive seizures J:113177
tonic-clonic seizures J:113177
\Fmr1tm1Cgr/Y
(either: FVB.129P2(B6)-Fmr1tm1Cgr/J or FVB;129P2(B6)-Fmr1tm1Cgr/J) 		audiogenic seizures J:85912
\Fmr1tm1Cgr/Y
\Grm5tm1Rod/\Grm5+
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		audiogenic seizures J:127792
\Fmr1tm1Rbd/Y
(B6.129-Fmr1tm1Rbd) 		audiogenic seizures J:155593
\Fosbtm1Brv/\Fosbtm1Brv
(involves: 129S2/SvPas) 		tonic-clonic seizures J:33415
\Fosbtm1Meg/\Fosbtm1Meg
(involves: 129S4/SvJae * 129X1/SvJ) 		abnormal seizure response to electrical stimulation J:110995
\Foxa2tm1Khk/\Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA) 		seizures J:70409
\Frrs1ltm1b(EUCOMM)Hmgu/\Frrs1ltm1b(EUCOMM)Hmgu
(C57BL/6N-Frrs1ltm1b(EUCOMM)Hmgu/H) 		seizures J:272893
\Fyntm1Sor/\Fyn+
\Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		tonic seizures J:59490
\Fyntm1Yik/\Fyntm1Yik
(involves: C57BL/6 * CBA) 		audiogenic seizures J:23384
\Fzd9tm1Sjp/\Fzd9tm1Sjp
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:99893
\G6pc1tm1Jyc/\G6pc1tm1Jyc
(involves: 129S4/SvJae) 		seizures J:33212
\G6pc1tm2.2Jyc/\G6pc1tm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		seizures J:155990
\Gabbr1tm1Bet/\Gabbr1tm1Bet
(BALB/c-Gabbr1tm1Bet) 		absence seizures J:70558
audiogenic seizures J:70558
clonic seizures J:70558
seizures J:70558
tonic-clonic seizures J:70558
\Gabbr1tm1Pngl/\Gabbr1tm1Pngl
(involves: 129P2/OlaHsd * C57BL/6J) 		sporadic seizures J:70254
tonic-clonic seizures J:70254
\Gabbr2tm1Arca/\Gabbr2tm1Arca
(involves: 129P2/OlaHsd) 		seizures J:146953
tonic-clonic seizures J:146953
\Gabbr2tm1Bet/\Gabbr2tm1Bet
(BALB/c-Gabbr2tm1Bet) 		clonic seizures J:103989
\Gabra1tm1.1Geh/\Gabra1+
(D2.129(Cg)-Gabra1tm1.1Geh) 		abnormal spike wave discharge J:186685
absence seizures J:186685
\Gabra1tm1.1Geh/\Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh) 		abnormal spike wave discharge J:186685, J:227437
absence seizures J:186685, J:227437
increased susceptibility to pharmacologically induced seizures J:227437
myoclonus J:227437
seizures J:227437
tonic-clonic seizures J:227437
\Gabra1tm1.1Mjga/\Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga) 		abnormal spike wave discharge J:227437
absence seizures J:227437
increased susceptibility to pharmacologically induced seizures J:227437
myoclonus J:227437
seizures J:227437
tonic-clonic seizures J:227437
\Gabra1tm1.1Uru/\Gabra1tm1.1Uru
(either: 129X1.129P2-Gabra1tm1.1Uru or B6.129P2-Gabra1tm1.1Uru) 		increased susceptibility to pharmacologically induced seizures J:75895
\Gabrb3tm1Geh/\Gabrb3tm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:39801
\Gabrb3tm2.1Geh/\Gabrb3tm2.1Geh
\Tg(Camk2a-cre)T29-1Stl/?
(involves: 129 * BALB/c * C57BL/6 * SJL) 		absence seizures J:127877
\Gabrb3tm2.1Uru/\Gabrb3tm2.1Uru
(B6J.129S6(Cg)-Gabrb3tm2.1Uru) 		increased susceptibility to pharmacologically induced seizures J:228332
\Gabrdtm1.1Jmag/\Gabrd+
\Gad2tm2(cre)Zjh/\Gad2+
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased susceptibility to pharmacologically induced seizures J:203336
\Gabrdtm1Geh/\Gabrdtm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		absence seizures J:64288
\Gabrg2tm1.2Rmac/\Gabrg2+
(involves: C57BL/6 * C57BL/6J * SJL) 		absence seizures J:306976
febrile seizures J:306976
increased susceptibility to pharmacologically induced seizures J:306976
myoclonus J:306976
seizures J:306976
tonic-clonic seizures J:306976
\Gabrg2tm1Spet/\Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		absence seizures J:127120
increased susceptibility to pharmacologically induced seizures J:127120
\Gabrg2tm1Spet/\Gabrg2+
(involves: 129 * BALB/cJ * C57BL/6 * DBA/2J) 		absence seizures J:127120
\Gabrg2tm1Spet/\Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		increased susceptibility to pharmacologically induced seizures J:194736
\Gabrg2tm1Spet/\Gabrg2tm1Spet
\n-TRtct5m1J/\n-TRtct5m1J
(B6.129(Cg)-Gabrg2tm1Spet/Frk) 		abnormal spike wave discharge J:297745
\Gabrg2tm1Spet/\Gabrg2tm1Spet
\n-TRtct5m1J/\n-TRtct5m1J
\Tg(n-TRtct5)574Slac/0
(B6.129(Cg)-Gabrg2tm1Spet Tg(n-TRtct5)574Slac) 		abnormal spike wave discharge J:297745
\Gabrg2tm2Lusc/\Gabrg2tm2Lusc
\Tg(Camk2a-cre)2834Lusc/0
(involves: 129P2/OlaHsd * 129X1/SvJ) 		seizures J:86221
\Gabrg2tm2Spet/\Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to pharmacologically induced seizures J:194196
\Gabrg2tm2Spet/\Gabrg2+
\Tg(Camk2a-tTA)1Mmay/0
\Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:194736
\Gad2tm1Bae/\Gad2tm1Bae
(involves: 129X1/SvJ * C57BL/6) 		seizures J:44638
\Gad2tm1Bae/\Gad2tm1Bae
(involves: 129X1/SvJ * NOD) 		seizures J:44638
\Gad2tm1Miya/\Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya) 		seizures J:88785
\Gad2tm1Oba/\Gad2+
(involves: C57BL/6 * CBA) 		seizures J:37576
\Gad2tm1Oba/\Gad2tm1Oba
(involves: C57BL/6 * CBA) 		myoclonus J:62320
seizures J:62320, J:37576
tonic-clonic seizures J:62320
\Galtm1Wyn/\Galtm1Wyn
(129P2-Galtm1Wyn) 		increased susceptibility to pharmacologically induced seizures J:77625
seizures J:77625
\Galctwi/\Galctwi
\Glb1tm1Adz/\Glb1+
(involves: 129P2/OlaHsd * C57BL/6J * CE/J) 		seizures J:63197
\Gantm1Yany/\Gantm1Yany
(Not Specified) 		seizures J:108239
\Gba1tm1Karl/\Gba1tm1Karl
\Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		seizures J:127108
\Gba1tm2Karl/\Gba1tm2Karl
\Tg(KRT14-cre)8Brn/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		seizures J:127108
\Gdi1tm1Ytk/\Gdi1tm1Ytk
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:65258
\Gfaptm2Mes/\Gfap+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:114689
\Gfaptm2Mes/\Gfap+
\Tg(GFAP)10Mes/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		seizures J:114689
\Gfra2tm1Msa/\Gfra2tm1Msa
(either: (involves: 129S1/Sv * 129S2/SvHsd * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NHsd)) 		decreased kindling response J:53284
\Gjb1tm1Kwi/Y
\Gjc2tm1(EGFP)Kwi/\Gjc2tm1(EGFP)Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		tonic seizures J:219594
\Gjc2tm1(EGFP)Kwi/\Gjc2tm1(EGFP)Kwi
\Gjb1tm1Kwi/\Gjb1tm1Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		seizures J:83885
sporadic seizures J:83885
tonic seizures J:83885, J:219594
\Gjc2tm1Paul/\Gjc2tm1Paul
\Gjb1tm1Kwi/\Gjb1tm1Kwi
(involves: 129/Sv * C57BL/6) 		tonic seizures J:84338
\Glra1nmf11/\Glra1nmf11
(C57BL/6J-Glra1nmf11/J) 		seizures J:78134
\Glra1spd-ot9J/\Glra1spd-ot9J
(B6.Cg-Glra1spd-ot9J/GrsrJ) 		tonic-clonic seizures J:234690
\Glra1tm1.1Geh/\Glra1tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177105
\Glra1tm1Rah/\Glra1tm1Rah
(involves: 129X1/SvJ * C57BL/6J) 		seizures J:85341
\Glra1tm2.1Geh/\Glra1tm2.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177106
\Glra3tm1Dgen/\Glra3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Glultm1.1Ncd/\Glultm1.1Ncd
\Emx1tm1(cre)Krj/\Emx1+
(B6.Cg-Glultm1.1Ncd Emx1tm1(cre)Krj) 		seizures J:272643
\Gna11tm1Soff/\Gna11tm1Soff
\Gnaqtm2Soff/\Gnaqtm2Soff
\Tg(Camk2a-cre)1Gsc/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N) 		clonic seizures J:111559
seizures J:111559
tonic-clonic seizures J:111559
\Gnao1em1Rneu/\Gnao1+
(involves: C57BL/6J * C57BL/6NCrl) 		increased kindling response J:271137
\Gnao1tm1Ejne/\Gnao1tm1Ejne
(involves: 129S4/SvJae * C57BL/6) 		sporadic seizures J:39013
\Gnao1tm2.1Rneu/\Gnao1+
(B6.129S-Gnao1tm2.1Rneu) 		abnormal kindling response J:216850
\Gnao1tm2Rneu/\Gnao1+
(involves: 129S1/Sv * C57BL/6J) 		abnormal spike wave discharge J:197965
\Gnb1em1Dgold/\Gnb1+
(C57BL/6NJ-Gnb1em1Dgold) 		abnormal spike wave discharge J:346983
minimal clonic seizures J:346983
\Gnb1em1Dgold/\Gnb1+
(involves: 129P2/OlaHsd * C57BL/6NJ * FVB) 		abnormal spike wave discharge J:346983
\Gnb5flr/\Gnb5flr
\Myo5aflr/\Myo5aflr
(involves: C57BL/6J * C57BL/10J * CBA/Ca) 		convulsive seizures J:61324
\Gng3tm1.1Rbs/\Gng3tm1.1Rbs
(involves: FVB/N) 		audiogenic seizures J:92791
convulsive seizures J:92791
\Gng3tm1.1Rbs/\Gng3tm1.1Rbs
(involves: C57BL/6J * FVB/N) 		audiogenic seizures J:92791
\Gng3tm1.1Rbs/\Gng3tm1.1Rbs
\Gng7tm1Lex/\Gng7tm1Lex
(B6.Cg-Gng7tm1Lex Gng3tm1.1Rbs) 		environmentally induced seizures J:182775
seizures J:182775
tonic-clonic seizures J:182775
\Gpx4tm2Marc/\Gpx4tm2Marc
\Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		convulsive seizures J:139668
\Gria2tm1Rsp/\Gria2+
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:30145
tonic-clonic seizures J:30145
\Gria2tm2.1Rsp/\Gria2+
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:51845
\Gria2tm2Rsp/\Gria2+
\Tg(Camk2a-cre)1Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		seizures J:111689
\Gria2tm2Rsp/\Gria2+
\Tg(Gria2*586N)238.2Rsp/0
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:51845
\Gria3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
\Gria3tm1Dgen/\Gria3tm1Dgen
\Gria4spkw1/\Gria4spkw1
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J) 		absence seizures J:135814
\Gria4spkw1/\Gria4+
(involves: C3H/HeJ * C3HeB/FeJ) 		absence seizures J:135814
\Gria4spkw1/\Gria4spkw1
(involves: C3H/HeJ * C57BL/6J) 		absence seizures J:98638
\Gria4spkw1/\Gria4spkw1
(C3H/HeJ) 		absence seizures J:135814
\Gria4spkw1/\Gria4spkw1
(involves: C3H/HeJ * C3HeB/FeJ) 		absence seizures J:135814
\Gria4spkw1/\Gria4spkw1
(C3Fe.C3-Gria4spkw1) 		abnormal spike wave discharge J:228536
\Gria4spkw1/\Gria4spkw1
\Pcnx2em1Frk/\Pcnx2em1Frk
(C3Fe.C3-Pcnx2em1Frk Gria4spkw1) 		abnormal spike wave discharge J:228536
\Gria4spkw1/\Gria4spkw1
\Pcnx2em5Frk/\Pcnx2em5Frk
(C3Fe.C3-Pcnx2em5Frk Gria4spkw1) 		abnormal spike wave discharge J:228536
\Gria4spkw1/\Gria4spkw1
\spkw2C3H/HeJ/\spkw2C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		absence seizures J:98638
\Gria4spkw1/\Gria4tm1Dgen
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J) 		absence seizures J:135814
\Gria4tm1Dgen/\Gria4+
(involves: 129P2/OlaHsd * C57BL/6J) 		absence seizures J:135814
\Gria4tm1Dgen/\Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal seizure response to pharmacological agent J:101679
\Gria4tm1Dgen/\Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		absence seizures J:135814
\Grik2tm1Bvis/\Grik2tm1Bvis
(129S/Sv-Grik2tm1Bvis) 		increased susceptibility to pharmacologically induced seizures J:107698
\Grik2tm1Sfh/\Grik2tm1Sfh
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:46932
\Grik4tm1(cre)Mim/\Grik4+
\Grin1tm1Mim/\Grin1tm1Mim
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:144994
tonic-clonic seizures J:144994
\Grik5tm1Dgen/\Grik5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Grin1tm1Blt/\Grin1tm1Blt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:62289
\Grin2atm1Rsp/\Grin2atm1Rsp
(involves: 129S1/Sv * 129X1/SvJ) 		decreased kindling response J:45446
\Grm5tm1Dgen/\Grm5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
increased susceptibility to pharmacologically induced seizures J:82809
\Grm7m1Btlr/\Grm7m1Btlr
(C57BL/6J-Grm7m1Btlr) 		convulsive seizures J:224658
\Grm7tm1Betz/\Grm7tm1Betz
(B6.129P2-Grm7tm1Betz) 		increased susceptibility to pharmacologically induced seizures J:138831
\Grm7tm1Dgen/\Grm7tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Grm7tm1Nak/\Grm7tm1Nak
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:52411
\Gsg1ltm1.2Tern/\Gsg1ltm1.2Tern
(C57BL/6J-Gsg1ltm1.2Tern) 		increased susceptibility to pharmacologically induced seizures J:301313
\Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn/\Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn
\Tg(Nes-cre)1Wmz/0
(involves: C57BL/6) 		seizures J:178712
\Gt(ROSA)26Sortm1(Crh)Jde/\Gt(ROSA)26Sortm1(Crh)Jde
\Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal seizure response to pharmacological agent J:140968
\Gt(ROSA)26Sortm1(DTA)Jpmb/\Gt(ROSA)26Sor+
\Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		seizures J:234435
\Gt(ROSA)26Sortm1.1(DUX4*)Plj/\Gt(ROSA)26Sor+
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6) 		seizures J:256652
\hael/\hael
(C3.Cg-H2p hael/GrsrJ) 		tonic seizures J:231653
\Hc1/\Hc1
\Tg(APPswe,PSEN1dE9)85Dbo/0
(D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo) 		convulsive seizures J:227541
\Hcn2ap/\Hcn2+
(DW/Pas-Hcn2ap) 		abnormal spike wave discharge J:146530
absence seizures J:146530
increased susceptibility to pharmacologically induced seizures J:146530
\Hcn2ap/\Hcn2ap
(DW/Pas-Hcn2ap) 		abnormal spike wave discharge J:146530
absence seizures J:146530
tonic-clonic seizures J:146530
\Hcn2tm1Ldw/\Hcn2tm1Ldw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		absence seizures J:81398
\Hcrtr1tm1Dgen/\Hcrtr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Hdac4Gt(OST361114)Lex/\Hdac4Gt(OST361114)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal spike wave discharge J:152466
convulsive seizures J:152466
environmentally induced seizures J:152466
tonic seizures J:152466
\Helttm1Wrst/\Helttm1Wrst
(B6.Cg-Helttm1Wrst) 		seizures J:119562
tonic-clonic seizures J:119562
\Hexatm1Grv/\Hexatm1Grv
(involves: 129P2/Ola * C57BL/6J) 		convulsive seizures J:88460
\Hexatm1Rlp/\Hexatm1Rlp
\Hexbtm1Rlp/\Hexbtm1Rlp
(involves: 129S4/SvJae * C57BL/6) 		sporadic seizures J:36305
\Hexbtm1Grv/\Hexbtm1Grv
(either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J)) 		abnormal seizure response to electrical stimulation J:30899
\Hnrnph2em1Jpat/Y
(C57BL/6J-Hnrnph2em1Jpat) 		audiogenic seizures J:338313
\Hnrnph2em1Jpat/\Hnrnph2+
(C57BL/6J-Hnrnph2em1Jpat) 		audiogenic seizures J:338313
\Hnrnph2em2Jpat/Y
(C57BL/6J-Hnrnph2em2Jpat) 		audiogenic seizures J:338313
\Hnrnph2em2Jpat/\Hnrnph2em2Jpat
(C57BL/6J-Hnrnph2em2Jpat) 		audiogenic seizures J:338313
\Hnrnpuem1Frk/\Hnrnpu+
(Not Specified) 		maximal tonic hindlimb extension seizures J:342579
\hpc/\hpc
(involves: STOCK Hps6ru f) 		clonic seizures J:64096
\Hpdlem1Jgg/\Hpdlem1Jgg
(C57BL/6-Hpdlem1Jgg) 		seizures J:334229
\Hprt1tm1(CAG-Glra3*)Jcme/Y
\Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:207981
\Hprt1tm1Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:44728
seizures J:44728
\Hprt1tm1Detl/\Hprt1tm1Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:44728
seizures J:44728
\Hprt1tm2Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
\Hprt1tm2Detl/\Hprt1tm2Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
\Hprt1tm4Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
\Hprt1tm4Detl/\Hprt1tm4Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
\Hprt1tm6Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
\Hprt1tm6Detl/\Hprt1tm6Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
\Hrh2tm1Yfks/\Hrh2tm1Yfks
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal seizure response to electrical stimulation J:102252
\Htr1atm1Toth/\Htr1atm1Toth
(involves: 129P2/OlaHsd * Black Swiss) 		increased susceptibility to pharmacologically induced seizures J:66581
\Htr2ctm1Jke/Y
(B6.129-Htr2ctm1Jke) 		tonic-clonic seizures J:147514
\Htr2ctm1Jke/Y
\Tg(Pomc1-cre)16Lowl/0
(B6.Cg-Htr2ctm1Jke Tg(Pomc1-cre)16Lowl) 		tonic-clonic seizures J:147514
\Htr2ctm1Jul/Y
(either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:24339
sporadic seizures J:24339
tonic seizures J:24339
tonic-clonic seizures J:24339
\Htr2ctm2Jke/Y
\Tg(Zp3-cre)93Knw/0
(involves: 129X1/SvJ * C57BL/6J) 		seizures J:207704
\Htr4tm1Comp/\Htr4tm1Comp
(129/Sv-Htr4tm1Comp) 		increased susceptibility to pharmacologically induced seizures J:87451
\Htr7tm1Wtkn/\Htr7tm1Wtkn
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal seizure response to electrical stimulation J:124549
increased susceptibility to pharmacologically induced seizures J:124549
\Htra2mnd2/\Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei) 		seizures J:50420
\Htttm1Detl/\Htttm1Detl
(involves: 129P2/OlaHsd * C57BL/6J) 		tonic-clonic seizures J:67074
\Htttm1Mem/\Htttm6Mem
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * Swiss Webster) 		environmentally induced seizures J:260244
\Htttm2Detl/\Htttm2Detl
(involves: 129P2/OlaHsd * C57BL/6J) 		tonic-clonic seizures J:67074, J:123681
\Htttm6Mem/\Htttm8Mem
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster) 		seizures J:72915
\Igsf9tm1Kln/\Igsf9tm1Kln
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:209586
\Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6J * CE/J) 		seizures J:63197
\Impa1Rgsc01846/\Impa1Rgsc01846
(B6NJcl.B6JJcl-Impa1Rgsc01846/Rbrc) 		seizures J:250420
\Impa1tm1Lex/\Impa1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:157887
\Iqsec2em1Csbg/Y
(C57BL/6NHsd-Iqsec2em1Csbg) 		sporadic seizures J:284750
\Iqsec2em1Csbg/\Iqsec2+
(C57BL/6NHsd-Iqsec2em1Csbg) 		sporadic seizures J:284750
\Iqsec2em1Frk/Y
(involves: C3HeB/FeJ * C57BL/6NJ) 		convulsive seizures J:284762
decreased susceptibility to induction of seizure by inducing agent J:284762
decreased susceptibility to pharmacologically induced seizures J:284762
\Iqsec2em1Frk/\Iqsec2+
(involves: C3HeB/FeJ * C57BL/6NJ) 		decreased susceptibility to induction of seizure by inducing agent J:284762
\Itgavtm2Hyn/\Itgavtm2.1Hyn
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB * SJL) 		convulsive seizures J:94376
seizures J:94376
\Itpr1opt/\Itpr1opt
(involves: C57BLKS) 		seizures J:50383, J:28829, J:37547
\Itpr1tm1Tno/\Itpr1tm1Tno
(involves: 129S4/SvJae * C57BL/6) 		seizures J:30633
tonic-clonic seizures J:30633
\jb/\jb
(involves: C3HeB/FeJ * C57BL/6J) 		convulsive seizures J:39707
\Juntm2.1Wag/\Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:53481
\Kcna1mceph/\Kcna1mceph
(BALB/cByJ-Kcna1mceph/J) 		convulsive seizures J:89910, J:119491
seizures J:89910
tonic-clonic seizures J:89910
\Kcna1tm1Tem/\Kcna1+
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
\Kcna1tm1Tem/\Kcna1tm1Tem
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
seizures J:47349
tonic-clonic seizures J:47349
\Kcna1tm1Tem/\Kcna1tm1Tem
(C3Fe.129S7-Kcna1tm1Tem) 		seizures J:206598
\Kcna1tm1Tem/\Kcna1tm1Tem
(involves: 129S7/SvEvBrd * C57BL/6) 		seizures J:77281
\Kcna1tm1Tem/\Kcna1tm1Tem
(involves: 129S7/SvEvBrd * BALB/cByJ * C3HeB/FeJ) 		convulsive seizures J:119491
\Kcna1tm1Tem/\Kcna1tm1Tem
(involves: 129S7/SvEvBrd) 		myoclonus J:164091
seizures J:164091
tonic-clonic seizures J:164091
\Kcna2tm1Tem/\Kcna2+
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
\Kcna2tm1Tem/\Kcna2tm1Tem
(involves: 129S7/SvEvBrd * C57BL/6) 		tonic seizures J:131735
\Kcna2tm1Tem/\Kcna2tm1Tem
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
tonic seizures J:131735
\Kcna2tm1Tem/\Kcna2tm1Tem
(involves: 129S7/SvEvBrd) 		seizures J:130097
\Kcna4tm1Lndn/\Kcna4tm1Lndn
(involves: 129S4/SvJae * C57BL/6) 		seizures J:48415
\Kcnab2tm1Kmc/\Kcnab2tm1Kmc
(involves: 129S7/SvEvBrd * C57BL/6) 		sporadic seizures J:75891
\Kcnc1tm1Joho/\Kcnc1tm1Joho
\Kcnc3tm1Echa/\Kcnc3tm1Echa
(involves: 129/Sv * C57BL/6) 		myoclonus J:71179
\Kcnc2tm1Rudy/\Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy) 		increased susceptibility to pharmacologically induced seizures J:66730
myoclonus J:66730
seizures J:66730
sporadic seizures J:66730
tonic-clonic seizures J:66730
\Kcnh3tm1.2Tije/\Kcnh3+
(involves: C57BL/6) 		abnormal spike wave discharge J:165296
\Kcnh3tm1.2Tije/\Kcnh3tm1.2Tije
(involves: C57BL/6) 		abnormal spike wave discharge J:165296
increased susceptibility to pharmacologically induced seizures J:165296
nonconvulsive seizures J:165296
\Kcnip1tm1Zhzh/\Kcnip1tm1Zhzh
(involves: C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:227383
\Kcnj6tm1Stf/\Kcnj6tm1Stf
(involves: 129S1/Sv * 129X1/SvJ) 		environmentally induced seizures J:38206
increased susceptibility to pharmacologically induced seizures J:38206
tonic-clonic seizures J:38206
\Kcnj6tm1Stf/\Kcnj6tm1Stf
\Kcnj9tm1Kwn/\Kcnj9tm1Kwn
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:77047
\Kcnj6wv/\Kcnj6wv
(C57BL/6J-Kcnj6wv) 		tonic-clonic seizures J:30520
\Kcnj10tm1Kdmc/\Kcnj10tm1Kdmc
\Tg(GFAP-cre)1Kdmc/?
(involves: 129S6/SvEvTac * C3H * C57BL/6 * C57BL/6J * SJL) 		tonic-clonic seizures J:126082
\Kcnj11tm1Sse/\Kcnj11tm1Sse
(involves: 129P2/OlaHsd) 		convulsive seizures J:69832
myoclonus J:69832
tonic-clonic seizures J:69832
\Kcnk2tm1Lzd/\Kcnk2tm1Lzd
(involves: 129 * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:91531
\Kcnmb4tm1Rwa/\Kcnmb4tm1Rwa
(involves: 129X1/SvJ * C57BL/6) 		nonconvulsive seizures J:103931
\Kcnq2Nmf134/\Kcnq2+
(C57BL/6J-Kcnq2Nmf134/J) 		abnormal seizure response to electrical stimulation J:82238
\Kcnq2Nmf134/\Kcnq2+
(C57BL/6J-Kcnq2Nmf134) 		abnormal seizure response to electrical stimulation J:136510
increased susceptibility to pharmacologically induced seizures J:136510
\Kcnq2Nmf134/\Kcnq2+
\Scn1atm1.1Aesc/\Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:170734
tonic-clonic seizures J:170734
\Kcnq2Nmf134/\Kcnq2+
\Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: C57BL/6J * SJL/J) 		seizures J:136510
tonic-clonic seizures J:136510
\Kcnq2Nmf134/\Kcnq2Nmf134
(C57BL/6J-Kcnq2Nmf134/J) 		abnormal seizure response to electrical stimulation J:82238
\Kcnq2tm1.1Lvi/\Kcnq2+
(129-Kcnq2tm1.1Lvi/Lvi) 		tonic-clonic seizures J:298666
\Kcnq2tm1.1Naas/\Kcnq2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal seizure response to electrical stimulation J:154582
\Kcnq2tm1.1Naas/\Kcnq2tm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:154582
\Kcnq2tm1.1Naas/\Kcnq2tm1.1Naas
(B6.129-Kcnq2tm1.1Naas) 		tonic-clonic seizures J:154582
\Kcnq2tm1.1Naas/\Kcnq2tm1.1Naas
(FVB.129-Kcnq2tm1.1Naas) 		seizures J:154582
\Kcnq2tm1Dgen/\Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Kcnq2tm1Hsa/\Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:62797
\Kcnq2tm2.1Snhr/\Kcnq2+
(B6.Cg-Kcnq2tm2.1Snhr) 		clonic seizures J:213443
\Kcnq2tm2.1Snhr/\Kcnq2tm2.1Snhr
(B6.Cg-Kcnq2tm2.1Snhr) 		clonic seizures J:213443
\Kcnq2tm3.1Snhr/\Kcnq2+
(B6.Cg-Kcnq2tm3.1Snhr) 		clonic seizures J:213443
\Kcnq3tm1.1Naas/\Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal seizure response to electrical stimulation J:154582
\Kcnq3tm1.1Naas/\Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		abnormal seizure response to electrical stimulation J:154582
\Kcnq3tm1.1Naas/\Kcnq3tm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:154582
\Kcnq3tm1.1Naas/\Kcnq3tm1.1Naas
(B6.129-Kcnq3tm1.1Naas) 		seizures J:154582
\Kcnq3tm1.1Naas/\Kcnq3tm1.1Naas
(FVB.129-Kcnq3tm1.1Naas) 		seizures J:154582
\Kcnt1em1Lekk/\Kcnt1+
(C57BL/6J-Kcnt1em1Lekk) 		increased susceptibility to pharmacologically induced seizures J:287751
seizures J:287751
\Kcnt1em1Pqt/\Kcnt1em1Pqt
(C57BL/6J-Kcnt1em1Pqt) 		seizures J:333512
tonic-clonic seizures J:333512
\Kcnt1em8Frk/\Kcnt1em8Frk
(C57BL/6NJ-Kcnt1em8Frk) 		seizures J:300699
tonic seizures J:300699
tonic-clonic seizures J:300699
\Kcnt1em8Frk/\Kcnt1em8Frk
(involves: 129P2/OlaHsd * C57BL/6NJ * FVB) 		seizures J:300699
\Kcnt1tm1.2Acsc/\Kcnt1tm1.2Acsc
(involves: 129 * C57BL/6N) 		abnormal seizure response to electrical stimulation J:287751
\Kdm1atm1Ebg/\Kdm1atm1Ebg
(B6.129-Kdm1atm1Ebg) 		absence seizures J:235553
decreased susceptibility to pharmacologically induced seizures J:235553
tonic-clonic seizures J:235553
\Kif4em1Noh/Y
(C57BL/6J-Kif4em1Noh) 		increased susceptibility to pharmacologically induced seizures J:336792
\Kif5atm1.2Noh/\Kif5atm1.2Noh
\Tg(Syn1-cre)671Jxm/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		seizures J:197666
\Kif5atm1Gsn/\Kif5atm2Gsn
\Tg(Syn1-cre)671Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		sporadic seizures J:82911
\Klk8tm1Lth/\Klk8tm1Lth
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:71533
\L2hgdhGt(DC0625)Wtsi/\L2hgdhGt(DC0625)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:228407
\Lamp5em1Lmit/\Lamp5+
(C57BL/6-Lamp5em1Lmit) 		increased susceptibility to pharmacologically induced seizures J:345459
\Lamp5em1Lmit/\Lamp5em1Lmit
(C57BL/6-Lamp5em1Lmit) 		increased susceptibility to pharmacologically induced seizures J:345459
\Letm1Gt(CC0204)Wtsi/\Letm1+
(129S.129P2-Letm1Gt(CC0204)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
\Letm1Gt(DD0926)Wtsi/\Letm1+
(129S.129P2-Letm1Gt(DD0926)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
\Lgi1tm1.1Ics/\Lgi1+
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		audiogenic seizures J:182795
\Lgi1tm1.1Ics/\Lgi1tm1.1Ics
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		abnormal spike wave discharge J:182795
environmentally induced seizures J:182795
seizures J:182795
tonic-clonic seizures J:182795
\Lgi1tm1.1Jkc/\Lgi1tm1.1Jkc
\Tyrc-Brd/\Tyrc-Brd
(B6.Cg-Tyrc-Brd Lgi1tm1.1Jkc) 		clonic seizures J:158715
seizures J:158715
\Lgi1tm1Mafu/\Lgi1+
(involves: 129S6/SvEvTac * C57BL/6) 		clonic seizures J:157578
increased susceptibility to pharmacologically induced seizures J:157578
tonic seizures J:157578
\Lgi1tm1Mafu/\Lgi1tm1Mafu
(involves: 129S6/SvEvTac * C57BL/6) 		seizures J:157578
tonic-clonic seizures J:157578
\Lgi1tm2.1Jkc/\Lgi1tm2.1Jkc
\Tg(CMV-cre)1Cgn/0
(involves: 129/Sv * BALB/cJ * C57BL/6) 		seizures J:269784
\Lgi1tm2.1Jkc/\Lgi1tm2.1Jkc
\Tg(Nes-cre)1Kln/0
(involves: 129/Sv * C57BL/6 * SJL) 		seizures J:269784
\Lhx6tm1Vpa/\Lhx6tm2Vpa
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal spike wave discharge J:198547
environmentally induced seizures J:198547
increased susceptibility to pharmacologically induced seizures J:198547
tonic-clonic seizures J:198547
\Loxl1tm1.1(KOMP)Vlcg/\Loxl1tm1.1(KOMP)Vlcg
(B6N(Cg)-Loxl1tm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
\Lpoem1Zlu/\Lpoem1Zlu
(involves: C57BL/6 * SJL) 		seizures J:307289
\Lrrc4btm1Lex/\Lrrc4btm1Lex
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:276446
\m154Asp/\m154Asp+
\Tg(Rr291-lacZ)#Mekk/0
(involves: C57BL/6J * FVB/N) 		sporadic seizures J:136795
\Mafgtm1Jeng/\Mafgtm1Jeng
\Mafktm1Jeng/\Mafk+
(involves: 129S1/Sv * 129X1/SvJ) 		myoclonus J:81813
\Magtm1.1(KOMP)Vlcg/\Magtm1.1(KOMP)Vlcg
(C57BL/6N-Magtm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
\Mapk10tm1Flv/\Mapk10tm1Flv
(involves: 129S1/Sv) 		decreased susceptibility to pharmacologically induced seizures J:43658
\Mapttm1Hnd/\Mapt+
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
\Mapttm1Hnd/\Mapt+
\Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
\Mapttm1Hnd/\Mapttm1Hnd
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
\Mapttm1Hnd/\Mapttm1Hnd
\Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
\Mbnl2tm1.1Sws/\Mbnl2+
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
\Mbnl2tm1.1Sws/\Mbnl2tm1.1Sws
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
tonic-clonic seizures J:218010
\Mbpjve/\Mbpjve
(involves: C57BL/6J) 		absence seizures J:221049
environmentally induced seizures J:221049
tonic seizures J:221049
\Mbpshi-mld+/\Mbpshi-mld+
(involves: C3H/HeJ * C57BL/6J * MDB/Dt) 		convulsive seizures J:1873
\Mbpshi-mld/\Mbpshi-mld
(involves: MDB/Dt) 		sporadic seizures J:5917
\Mbpshi/\Mbpshi
(involves: C3H * ICR * SWV) 		audiogenic seizures J:6578
environmentally induced seizures J:6578
tonic seizures J:6578
\Mbpshi/\Mbpshi
\Tg(Thy1-YFP)HJrs/0
(involves: C3HeB/Fe * C57BL/6 * CBA * SWV) 		increased susceptibility to pharmacologically induced seizures J:158545
\Mc2rtm1Dgen/\Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
\Mcoln3Va/\Mcoln3+
(involves: C57BL * C57BR) 		tonic seizures J:13133
\Mcoln3Va/\Mcoln3Va
(involves: C57BL * C57BR) 		tonic seizures J:13133
\Mecp2em1Jlzn/Y
(C57BL/6-Mecp2em1Jlzn) 		environmentally induced seizures J:296009
seizures J:296009
\Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		seizures J:166851
\Mecp2tm1.1Dhy/Y
(C57BL/6N-Mecp2tm1.1Dhy) 		seizures J:209069
\Mecp2tm1.1Irsf/\Mecp2+
(involves: 129S2/SvPas * C57BL/6) 		tonic-clonic seizures J:220859
\Mecp2tm1.1Joez/Y
(B6.129-Mecp2tm1.1Joez) 		seizures J:181311
\Mecp2tm1.1Jtc/\Mecp2+
(involves: 129S6/SvEvTac * C57BL/6) 		tonic-clonic seizures J:209637
\Mecp2tm1Bird/Y
\Ssttm2.1(cre)Zjh/\Sst+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		seizures J:228740
tonic-clonic seizures J:228740
\Mecp2tm1Hzo/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		seizures J:78009
\Mecp2tm1Pplt/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		sporadic seizures J:137513
\Mecp2tm3Meg/Y
(B6.129-Mecp2tm3Meg) 		increased susceptibility to pharmacologically induced seizures J:204723
\Mir128-2tm1.1Ans/\Mir128-2tm1.1Ans
\Tg(Camk2a-cre)2Gsc/0
(involves: BALB/cJ * C57BL/6J * FVB/N) 		seizures J:205260
\Mir128-2tm1.1Ans/\Mir128-2tm1.1Ans
\Tg(Drd1-cre)EY262Gsat/0
(involves: BALB/cJ * C57BL/6J * FVB/N) 		seizures J:205260
\Mir128-2tm1.2Ans/\Mir128-2tm1.2Ans
(involves: BALB/cJ * C57BL/6J) 		seizures J:205260
\Mir145atm1Eno/\Mir145atm1Eno
(involves: 129S/SvEv * C57BL/6) 		seizures J:152458
\Mirc32tm1.2Eno/\Mirc32tm1.2Eno
(involves: 129S/SvEv * C57BL/6) 		seizures J:152458
\Mldhrtm1Zhgn/\Mldhrtm1Zhgn
\Tg(GFAP-cre)25Mes/0
(involves: FVB/N) 		seizures J:303725
\Msx2tm1Rilm/\Msx2tm1Rilm
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6J)) 		tonic seizures J:61509
\Mt1tm1Bri/\Mt1tm1Bri
\Mt2tm1Bri/\Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		clonic seizures J:89429
increased susceptibility to pharmacologically induced seizures J:89429
tonic-clonic seizures J:89429
\Mt3tm1Rpa/\Mt3tm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38222
\Mtmr9tm1Wum/\Mtmr9+
(Not Specified) 		seizures J:336167
\MvpGt(IST10954E2)Tigm/\Mapk3tm1Gpg
(involves: 129 * C57BL/6J * C57BL/6N) 		decreased susceptibility to pharmacologically induced seizures J:343325
\Myo3btm1b(EUCOMM)Hmgu/\Myo3btm1b(EUCOMM)Hmgu
(C57BL/6N-Myo3btm1b(EUCOMM)Hmgu/J) 		convulsive seizures J:211773
\Myo5ad-15H/\Myo5ad-15H
(Not Specified) 		seizures J:13409
\Myo5ad-l32J/\Myo5ad-l32J
(B6.Cg-Myo5ad-l32J/GrsrJ) 		clonic seizures J:169210
\Myo5ad-l/\Myo5ad-l
(involves: C57BL) 		clonic seizures J:12978
\Myo5ad-n2Btlr/\Myo5ad-n2Btlr
(C57BL/6J-Myo5ad-n2Btlr) 		myoclonus J:133120
\Myo5ad-n/\Myo5ad-n
(B10.D2-H2d/nSnJ) 		clonic seizures J:171603
\Myo5ad-nBtlr/\Myo5ad-nBtlr
(C57BL/6J-Myo5ad-nBtlr) 		myoclonus J:133119
\Myo9aem1Atuf/\Myo9aem1Atuf
(C57BL/6J-Myo9aem1Atuf) 		seizures J:302901
\Myrftm1Barr/\Myrftm1Barr
\Cnptm1(cre)Kan/\Cnp+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		seizures J:150563
\Myrftm1Barr/\Myrftm1Barr
\Olig2tm2(TVA,cre)Rth/\Olig2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		seizures J:150563
\n-TRtct5m1J/\n-TRtct5m1J
(C57BL/6J) 		abnormal seizure response to electrical stimulation J:297745
abnormal seizure response to pharmacological agent J:297745
\n-TRtct5tm1.1Slac/\n-TRtct5tm1.1Slac
(C57BL/6J-n-TRtct5tm1.1Slac) 		abnormal seizure response to electrical stimulation J:297745
abnormal seizure response to pharmacological agent J:297745
\n-TRtct5tm2.1Slac/\n-TRtct5tm2.1Slac
(C57BL/6NJ-n-TRtct5tm2.1Slac) 		abnormal seizure response to pharmacological agent J:297745
\Nacc1em1Mdif/\Nacc1+
(C57BL/6-Nacc1em1Mdif) 		seizures J:354196
\Nacc1em1Mdif/\Nacc1em1Mdif
(C57BL/6-Nacc1em1Mdif) 		seizures J:354196
\Napbtm1Bros/\Napbtm1Bros
(Not Specified) 		seizures J:167753
\Ncdntm2Afu/\Ncdntm2Afu
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		seizures J:99914
\Ndufs4tm1.1Rpa/\Ndufs4tm1.1Rpa
(involves: 129S4/SvJaeSor) 		environmentally induced seizures J:161393
seizures J:161393
\Ndufs4tm1Rpa/\Ndufs4tm1Rpa
\Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL) 		environmentally induced seizures J:161393
seizures J:161393
tonic-clonic seizures J:161393
\nerv/\nerv
(BALB/c-nerv) 		seizures J:227974
\Neto1tm1Mci/\Neto1tm1Mci
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:145953
\Neu1tm1Adz/\Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI)) 		myoclonus J:76937
\Neurod1tm1Mjts/\Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J) 		seizures J:59932
sporadic seizures J:59932
tonic-clonic seizures J:59932
\Neurod2tm1Tap/\Neurod2+
(involves: 129/Sv * C57BL/6) 		sporadic seizures J:69606
tonic-clonic seizures J:69606
\Neurod2tm1Tap/\Neurod2tm1Tap
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69606
\Nexmiftm1(KOMP)Wtsi/Y
(B6J.B6N-Nexmiftm1(KOMP)Wtsi) 		seizures J:283395
\Nf1tm1Par/\Nf1+
\Ptentm1Hwu/\Pten+
\Trp53tm1Elee/\Trp53+
\Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N) 		seizures J:134611
\Nf1tm1Par/\Nf1+
\Ptentm1Hwu/\Pten+
\Trp53tm1Tyj/\Trp53+
\Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S2/SvPas * 129S4/SvJae * 129X1/SvJ * FVB/N) 		seizures J:134611
\Nf1tm1Par/\Nf1+
\Trp53tm1Elee/\Trp53+
\Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N) 		seizures J:134611
\Nhlrc1tm1(KOMP)Vlcg/\Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased susceptibility to pharmacologically induced seizures J:218959
\Nhlrc1tm1(KOMP)Vlcg/\Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
\Nhlrc1tm1(KOMP)Vlcg/\Nhlrc1tm1(KOMP)Vlcg
\Gys1tm1c(EUCOMM)Wtsi/\Gys1+
\Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
\Nhlrc1tm1(KOMP)Vlcg/\Nhlrc1tm1(KOMP)Vlcg
\Gys1tm1c(EUCOMM)Wtsi/\Gys1tm1c(EUCOMM)Wtsi
\Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
\Nhlrc1tm1.2Geno/\Nhlrc1tm1.2Geno
(involves: 129S2/SvPas * C57BL/6J) 		abnormal spike wave discharge J:181559
myoclonus J:181559
\Nid1tm1Dong/\Nid1tm1Dong
(involves: 129P2/OlaHsd) 		sporadic seizures J:80843
\Nmf31/\Nmf31
(BALB/cByJ-Nmf31/J) 		myoclonus J:87349
\Nmf31/\Nmf31+
(BALB/cByJ-Nmf31/J) 		minimal clonic seizures J:78134
\nmf88/\nmf88
(C57BL/6J-nmf88/J) 		abnormal seizure response to electrical stimulation J:82238
\nmf391/\nmf391
(C57BL/6J-nmf391/J) 		myoclonus J:87349
\Nos1tm1Plh/\Nos1tm1Plh
(B6.129S4-Nos1tm1Plh) 		abnormal seizure response to inducing agent J:107964
\Nos2tm1Lau/\Nos2tm1Lau
(B6.129P2-Nos2tm1Lau) 		increased susceptibility to pharmacologically induced seizures J:107300
\Nos3tm1Plh/\Nos3tm1Plh
(B6.129S4-Nos3tm1Plh) 		abnormal seizure response to inducing agent J:107964
\Npas4tm1Meg/\Npas4tm1Meg
(involves: C57BL/6) 		seizures J:143367
\Npas4tm1Ooe/\Npas4tm1Ooe
(involves: 129/Sv * C57BL/6) 		myoclonus J:145569
\Npy2rtm1.1Hhz/\Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:124729
\Npytm1Rpa/\Npytm1Rpa
(involves: 129S7/SvEvBrd) 		increased susceptibility to pharmacologically induced seizures J:33261
sporadic seizures J:33261
\Npytm2Rpa/\Npytm2Rpa
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:104699
\Nr4a3tm1Omc/\Nr4a3tm1Omc
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:93320
tonic-clonic seizures J:93320
\Nrcamtm2e.1(KOMP)Wtsi/\Nrcamtm2e.1(KOMP)Wtsi
(C57BL/6N-Nrcamtm2e.1(KOMP)Wtsi/J) 		convulsive seizures J:211773
\Nrp2tm1.2Mom/\Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		environmentally induced seizures J:166116
increased susceptibility to pharmacologically induced seizures J:166116
myoclonus J:166116
seizures J:166116
\Nrp2tm1.2Mom/\Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		environmentally induced seizures J:166116
increased susceptibility to pharmacologically induced seizures J:166116
myoclonus J:166116
seizures J:166116
\Ntrk2tm1Jom/\Ntrk2+
\Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		decreased kindling response J:91467
\Ntrk2tm1Jom/\Ntrk2tm1Jom
\Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		decreased kindling response J:91467
\nur8/\nur8
(Not Specified) 		seizures J:85113
\nur33/\nur33
(Not Specified) 		myoclonus J:89098
\Nur37/\Nur37+
(Not Specified) 		seizures J:89098
\Oprd1tm1Dgen/\Oprd1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Otcspf/Y
(involves: C3H/HeJ * C57BL/6J) 		tonic-clonic seizures J:31237
\Otud7aem1Cpsc/\Otud7aem1Cpsc
(C57BL/6J-Otud7aem1Cpsc) 		abnormal spike wave discharge J:259730
\Otx1tm1Asim/\Otx1tm1Asim
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		convulsive seizures J:35640
nonconvulsive seizures J:35640
\Otx1tm1Asim/\Otx1tm1Asim
(involves: 129P2/OlaHsd) 		seizures J:52989
\P2rx6tm1Dgen/\P2rx6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
\Pacsin1tm1.1Bqu/\Pacsin1tm1.1Bqu
(Not Specified) 		tonic-clonic seizures J:180017
\Pahm1Btlr/\Pahm1Btlr
(C57BL/6J-Pahm1Btlr) 		audiogenic seizures J:152890
environmentally induced seizures J:152890
\Panx1tm1.1Fama/\Panx1tm1.1Fama
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:177671
\Panx1tm1a(KOMP)Wtsi/\Panx1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased susceptibility to pharmacologically induced seizures J:177671
\Pcmt1tm1Scl/\Pcmt1tm1Scl
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40967
tonic-clonic seizures J:40967
\Pcmt1tm1Shs/\Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6) 		clonic seizures J:46228
convulsive seizures J:46228
myoclonus J:46228
tonic-clonic seizures J:46228
\Pcntm239Asp/\Pcnt+
\Tg(Rr291-lacZ)#Mekk/0
(involves: C57BL/6J * FVB/N) 		sporadic seizures J:136795
\Pcntm275Asp/\Pcnt+
\Tg(Rr291-lacZ)#Mekk/0
(involves: C57BL/6J * FVB/N) 		sporadic seizures J:136795
\Pde8atm1Dgen/\Pde8atm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
\Pdgfratm6Sor/\Pdgfratm6Sor
(either: 129S4/SvJaeSor-Pdgfratm6Sor or (involves: 129S4/SvJaeSor * C57BL/6J)) 		seizures J:73817
\Pdyntm1(cre)Czer/\Pdyn+
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
\Pdyntm1(cre)Czer/\Pdyntm1(cre)Czer
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
\Phf6em1Azbi/Y
(B6.Cg-Phf6em1Azbi) 		increased susceptibility to pharmacologically induced seizures J:271089
\Pis1A/J/\Pis1A/J
(C57BL/6J-Chr 10A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
\Pis2A/J/\Pis2A/J
(C57BL/6J-Chr 18A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
\PitpnaGt(OST1152)Lex/\PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd) 		seizures J:85204
\Pitpnatm1Vab/\Pitpnatm1Vab
(involves: 129S7/SvEvBrd) 		seizures J:85204
\Plaurtm1Mlg/\Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg) 		increased susceptibility to pharmacologically induced seizures J:81735
myoclonus J:81735
\Plcb1tm1Hssh/\Plcb1tm1Hssh
(Not Specified) 		convulsive seizures J:43077
increased susceptibility to pharmacologically induced seizures J:43077
\Plcl1tm1Mh/\Plcl1tm1Mh
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:92956
seizures J:92956
\Plp1jp-4J/Y
(involves: C3H/HeJ * C57BL/6J) 		seizures J:41569
\Plp1jp-msd/Y
(involves: C57BL/10Sn * BALB/cJ) 		seizures J:5170
\Plp1jp-rsh/Y
(involves: C57BL/6NCrl) 		seizures J:88023
\Plp1jp/Y
(Not Specified) 		environmentally induced seizures J:288
tonic-clonic seizures J:13141
\Plppr4tm1Roni/\Plppr4tm1Roni
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:157318
tonic-clonic seizures J:157318
\Plppr5em2Gpt/\Plppr5em2Gpt
(C57BL/6-Plppr5em2Gpt) 		increased susceptibility to pharmacologically induced seizures J:324004
\Pmp22tm1Ueli/\Pmp22tm1Ueli
(involves: 129S/SvEv) 		convulsive seizures J:29517
\Pmp22Tr/?
(Not Specified) 		seizures J:7222
\Pmp22Tr/\Pmp22+
(Not Specified) 		convulsive seizures J:13038
\Ppargc1atm1Brsp/\Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N) 		myoclonus J:93896
\Ppp1r9btm1Jfe/\Ppp1r9btm1Jfe
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:77284
\Ppt1tm1Aj/\Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6) 		myoclonus J:95522
seizures J:95522
\Ppt1tm1Hof/\Ppt1tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J) 		myoclonus J:72931
\Prickle1em1Yzou/\Prickle1+
(C57BL/6-Prickle1em1Yzou) 		increased susceptibility to pharmacologically induced seizures J:321396
\Prickle1m1Ingm/\Prickle1+
(involves: C57BL/6) 		abnormal seizure response to electrical stimulation J:169136
\Prickle1m2Ingm/\Prickle1+
(C57BL/6-Prickle1m2Ingm) 		abnormal seizure response to electrical stimulation J:169136
\Prickle1tm1Nue/\Prickle1+
(B6.Cg-Prickle1tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
\Prickle2tm1Nue/\Prickle2+
(B6.Cg-Prickle2tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
\Prickle2tm1Nue/\Prickle2tm1Nue
(B6.Cg-Prickle2tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
increased susceptibility to pharmacologically induced seizures J:169136
\Prkab1Gt(RRR454)Byg/\Prkab1Gt(RRR454)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:146618
\Prnptm1Cwe/\Prnptm1Cwe
\Tg(Prnp*)#Rgab/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		myoclonus J:183170
\Prrt2tm1a(KOMP)Wtsi/\Prrt2tm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Prrt2tm1a(KOMP)Wtsi/Wtsi) 		audiogenic seizures J:237823
increased susceptibility to pharmacologically induced seizures J:237823
\Psaptm1Suz/\Psaptm1Suz
(involves: 129P2/OlaHsd) 		seizures J:113052
tonic seizures J:33477
\Psaptm2Suz/\Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J) 		seizures J:78223
\psrt1R/\psrt1R
(involves: BJR) 		seizures J:73982
\psrt2R/\psrt2R
(involves: BJR) 		seizures J:73982
\Ptentm1Rdp/\Pten+
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		seizures J:140704
\Ptentm2Mak/\Ptentm2Mak
\Tg(Eno2-cre)39Jme/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		sporadic seizures J:109635
\Ptentm2Mak/\Ptentm2Mak
\Tg(Gfap-cre)1Sbk/0
(involves: 129P2/OlaHsd) 		abnormal spike wave discharge J:149829
seizures J:75500
tonic-clonic seizures J:149829
\Ptentm2Mak/\Ptentm2Mak
\Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd) 		seizures J:237990
\Ptgs2tm1Unc/\Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac) 		increased susceptibility to pharmacologically induced seizures J:141610
tonic-clonic seizures J:141610
\Ptprotm1Dgen/\Ptprotm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Puratm1Kkh/\Pura+
(involves: 129) 		seizures J:85759
\Puratm1Kkh/\Puratm1Kkh
(involves: 129) 		seizures J:85759
\Qkie5/\Qkie5
(B6.101Rl-Qkie5) 		seizures J:102038
\Qkie5/\Qkiqk-k2
(involves: 101/Rl * C57BL/6J * CBA/Ca) 		seizures J:102038
\Qkie5/\Qkiqk-kt1
(involves: 101/Rl * C57BL/6J) 		seizures J:102038
\Qkiqk-shk/\Qkiqk-shk
(involves: 129 * C57BL/6) 		tonic seizures J:220956
\Qkiqk-v/\Qkiqk-v
(B6C3Fe a/a-Qkiqk-v/J) 		seizures J:102038
\Qkiqk-v/\Qkiqk-v
(involves: C3H/Di * DBA/2J) 		tonic seizures J:13141
\Rai1tm1Jrl/\Rai1+
(involves: 129S/SvEvBrd * C57BL/6) 		seizures J:125089
\Rai1tm1Jrl/\Rai1tm1Jrl
(involves: 129S/SvEvBrd * C57BL/6) 		seizures J:125089
tonic-clonic seizures J:125089
\Rbfox1tm1.1Dblk/\Rbfox1+
\Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
\Rbfox1tm1.1Dblk/\Rbfox1tm1.1Dblk
\Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
seizures J:176189
tonic-clonic seizures J:176189
\Rbfox3tm1a(EUCOMM)Hmgu/\Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H) 		increased susceptibility to pharmacologically induced seizures J:234043
\Rgsc73/\Rgsc73+
(involves: C57BL/6JJcl * DBA/2JJcl) 		convulsive seizures J:133634
\Rnd3Gt(OST364657)Lex/\Rnd3Gt(OST364657)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		convulsive seizures J:172361
\Rnf10tm1b(KOMP)Wtsi/\Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/J) 		convulsive seizures J:211773
\Rogditm1.2Ics/\Rogditm1.2Ics
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:344072
\Ryr2tm1Slh/\Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:235432
\Ryr2tm2Amks/\Ryr2+
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
tonic-clonic seizures J:137696
\Ryr2tm2Amks/\Ryr2tm2Amks
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
tonic-clonic seizures J:137696
\S1pr2tm1Ajml/\S1pr2tm1Ajml
(involves: 129S5/SvEvBrd * C57BL/6) 		seizures J:73957
tonic-clonic seizures J:73957
\S1pr2tm1Ajml/\S1pr2tm1Ajml
(either: (involves: 129S5/SvEvBrd) or (involves: 129S5/SvEvBrd * C57BL/6)) 		seizures J:112371
\S1pr2tm1Ytak/\S1pr2tm1Ytak
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:168060
\Scamp5tm1Smoc/\Scamp5tm1Smoc
(involves: C57BL/6J) 		audiogenic seizures J:288324
seizures J:288324
\Scg5tm1Led/\Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		convulsive seizures J:77510
\Scn1aem1Anord/\Scn1a+
(C57BL/6N-Scn1aem1Anord) 		abnormal spike wave discharge J:333350
environmentally induced seizures J:333350
increased susceptibility to pharmacologically induced seizures J:333350
\Scn1aem1Anord/\Scn1aem1Anord
(C57BL/6N-Scn1aem1Anord) 		environmentally induced seizures J:333350
\Scn1atm1.1Aesc/\Scn1a+
(involves: 129X1/SvJ * C57BL/6J * SJL) 		abnormal spike wave discharge J:161191
environmentally induced seizures J:161191
increased susceptibility to pharmacologically induced seizures J:161191
seizures J:161191
tonic seizures J:161191
tonic-clonic seizures J:161191
\Scn1atm1.1Aesc/\Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:170734
\Scn1atm1.1Aesc/\Scn1a+
\Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J * SJL/J) 		convulsive seizures J:170734
tonic-clonic seizures J:170734
\Scn1atm1.1Aesc/\Scn1atm1.1Aesc
(involves: 129X1/SvJ * C57BL/6J * SJL) 		clonic seizures J:161191
environmentally induced seizures J:161191
maximal tonic hindlimb extension seizures J:161191
seizures J:161191
tonic seizures J:161191
\Scn1atm1.1Kzy/\Scn1a+
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:121969
\Scn1atm1.1Kzy/\Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		convulsive seizures J:209093
increased susceptibility to pharmacologically induced seizures J:209093
\Scn1atm1.1Kzy/\Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		environmentally induced seizures J:260796
seizures J:260796
\Scn1atm1.1Swl/\Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl) 		environmentally induced seizures J:221045
tonic-clonic seizures J:221045
\Scn1atm1.1Swl/\Scn1atm1.1Swl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl) 		tonic-clonic seizures J:221045
\Scn1atm1Kea/\Scn1a+
((C57BL/6J x 129S6/SvEvTac-Scn1atm1Kea)F1) 		seizures J:203040
\Scn1atm1Kzy/\Scn1a+
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:121969
\Scn1atm1Kzy/\Scn1atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:121969
tonic seizures J:121969
tonic-clonic seizures J:121969
\Scn1atm1Wac/\Scn1a+
(B6.129-Scn1atm1Wac) 		seizures J:113149
\Scn1atm1Wac/\Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * FVB/NJ) 		abnormal spike wave discharge J:129998
increased susceptibility to pharmacologically induced seizures J:129998
tonic-clonic seizures J:129998
\Scn1atm1Wac/\Scn1a+
\Scn8amed-jo/\Scn8a+
(involves: 129 * C57BL/6J * DBA/2WyDi * FVB/NJ) 		abnormal spike wave discharge J:129998
\Scn1atm1Wac/\Scn1atm1Wac
(B6.129-Scn1atm1Wac) 		clonic seizures J:113149
convulsive seizures J:113149
seizures J:113149
\Scn1atm2.1Kzy/\Scn1a+
\Tg(Pvalb-cre)1Tama/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		convulsive seizures J:202863
\Scn1atm2.1Kzy/\Scn1a+
\Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:202863
\Scn1atm2.1Kzy/\Scn1atm2.1Kzy
\Tg(Pvalb-cre)1Tama/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		convulsive seizures J:202863
\Scn1atm2.1Kzy/\Scn1atm2.1Kzy
\Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:202863
\Scn1atm2.1Wac/\Scn1a+
\Tg(I12b-cre)1Jlr/0
(involves: C57BL/6J * CD-1) 		clonic seizures J:189897
environmentally induced seizures J:189897
seizures J:189897
tonic-clonic seizures J:189897
\Scn1atm2.2Kzy/\Scn1a+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		convulsive seizures J:202863
\Scn1atm2.2Kzy/\Scn1atm2.2Kzy
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		convulsive seizures J:202863
\Scn1btm1.1Bion/\Scn1b+
(Not Specified) 		environmentally induced seizures J:163771
\Scn1btm1.1Bion/\Scn1btm1.1Bion
(Not Specified) 		environmentally induced seizures J:163771
seizures J:163771
tonic-clonic seizures J:163771
\Scn1btm1Isom/\Scn1btm1Isom
(involves: 129X1/SvJ * C57BL/6) 		seizures J:90136
\Scn1btm2.1Isom/\Scn1btm2.1Isom
(involves: 129X1/SvJ * C57BL/6) 		seizures J:128713
\Scn2btm1Isom/\Scn2btm1Isom
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82050
\Scn5atm1Clhh/\Scn5a+
(involves: 129 * 129S/SvEv * C57BL/6J) 		seizures J:127879
\Scn8a7J/\Scn8a7J
(involves: BALB/cByJ * C57BL/6J) 		myoclonus J:87349
\Scn8a8J/\Scn8a8J
(involves: C3HeB/FeJ * C57BL/6J) 		abnormal spike wave discharge J:147199
\Scn8a8J/\Scn8a+
(involves: C3HeB/FeJ * C57BL/6J) 		abnormal spike wave discharge J:147199
\Scn8aem1Mm/\Scn8a+
(involves: C57BL/6J * SJL) 		seizures J:207931
\Scn8amed-jo/\Scn8a+
(B6.D2-Scn8amed-jo/J) 		abnormal spike wave discharge J:147199
decreased susceptibility to pharmacologically induced seizures J:170734, J:129998
\Scn8amed/\Scn8a+
(C3Fe.Cg-Scn8amed/J) 		abnormal spike wave discharge J:147199
decreased susceptibility to pharmacologically induced seizures J:129998
\Scn9atm1.1Naas/\Scn9atm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal seizure response to electrical stimulation J:154118
minimal clonic seizures J:154118
\Scn9atm1.1Naas/\Scn9atm1.1Naas
(B6.129-Scn9atm1.1Naas) 		abnormal kindling response J:154118
\Seh1ltm1Lzha/\Seh1ltm1Lzha
\Olig1tm1(cre)Rth/\Olig1+
(involves: 129S4/SvJae * C57BL/6) 		seizures J:276253
\Senp2tm1Eyeh/\Senp2tm1Eyeh
(Not Specified) 		audiogenic seizures J:217910
convulsive seizures J:217910
\Serpine2tm1Dmn/\Serpine2tm1Dmn
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40953
\Sez6tm1.1Sest/\Sez6tm1.1Sest
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:132725
\Sgcetm1Ygl/\Sgce+
(involves: 129S2/SvPas) 		myoclonus J:180682
\Sgcetm1Ygl/\Sgcetm1Ygl
(involves: 129S2/SvPas * 129S4/SvJaeSor * BALB/c * C57BL/6) 		myoclonus J:101332
\Sh3gl1tm1Pdc/\Sh3gl1tm1Pdc
\Sh3gl2tm1Pdc/\Sh3gl2+
\Sh3gl3tm1.2Itl/\Sh3gl3tm1.2Itl
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * FVB/N * SJL) 		seizures J:178947
\Sh3gl1tm1Pdc/\Sh3gl1tm1Pdc
\Sh3gl2tm1Pdc/\Sh3gl2tm1Pdc
(involves: 129) 		seizures J:178947
\Sh3rf2tm1Zhxu/\Sh3rf2+
(C57BL/6-Sh3rf2tm1Zhxu) 		seizures J:270945
\Shank3tm1.1Cya/\Shank3tm1.1Cya
(B6.Cg-Shank3tm1.1Cya) 		decreased susceptibility to pharmacologically induced seizures J:281328
\Shank3tm2Gfng/\Shank3tm2Gfng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:171113
\Shhtm2Amc/\Shhtm2Amc
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		seizures J:102950
\Sicd1C57BL/6J/\Sicd1C57BL/6J
(FVB.B6-(D18Mit141-D18Mit25)) 		increased susceptibility to pharmacologically induced seizures J:122922
\sims/\sims
(B6.Cg-sims/GrsrJ) 		audiogenic seizures J:161505
\sims/\sims+
(B6.Cg-sims/GrsrJ) 		environmentally induced seizures J:161505
\Sipa1l1tm1Taki/\Sipa1l1tm1Taki
(B6.Cg-Sipa1l1tm1Taki/Taki) 		increased susceptibility to pharmacologically induced seizures J:345320
\Slc1a2tm1.1Ncd/\Slc1a2tm1.1Ncd
\Tg(Nes-cre)1Kln/0
(B6.Cg-Slc1a2tm1.1Ncd Tg(Nes-cre)1Kln) 		seizures J:207177
\Slc1a2tm1.1Pros/\Slc1a2tm1.1Pros
\Tg(GFAP-cre/ERT2)13Kdmc/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6) 		seizures J:221590
\Slc1a2tm1Kta/\Slc1a2tm1Kta
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:40984
increased susceptibility to pharmacologically induced seizures J:40984
\Slc1a3tm1Kta/\Slc1a3tm1Kta
(involves: 129P2/OlaHsd) 		abnormal kindling response J:58180
increased susceptibility to pharmacologically induced seizures J:58180
seizures J:58180
\Slc2a1Rgsc200/\Slc2a1+
(involves: C57BL/6JJcl * DBA/2JJcl) 		convulsive seizures J:281292
environmentally induced seizures J:281292
\Slc2a1Rgsc200/\Slc2a1+
(B6(D2)-Slc2a1Rgsc200) 		sporadic seizures J:281292
\Slc2a1tm1Dcdv/\Slc2a1+
(involves: 129S6/SvEvTac * C57BL/6J) 		sporadic seizures J:108250
\Slc4a3tm1Cahb/\Slc4a3tm1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:104157
\Slc4a10tm1.1Cahb/\Slc4a10tm1.1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:131058
\Slc6a5trsl/\Slc6a5trsl
(C57BL/6J-Slc6a5trsl/GrsrJ) 		tonic seizures J:235637
\Slc6a11tm1Dgen/\Slc6a11+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
\Slc7a8tm1Dgen/\Slc7a8tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
\Slc7a10tm1Dgen/\Slc7a10tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		myoclonus J:100127
seizures J:100127
tonic-clonic seizures J:100127
\Slc9a1swe/\Slc9a1swe
(SJL/J-Slc9a1swe/J) 		seizures J:43429
tonic-clonic seizures J:43429
\Slc9a1swe/\Slc9a1swe
(B6.SJL-Slc9a1swe) 		seizures J:43429
tonic-clonic seizures J:43429
\Slc9a1swe/\Slc9a1swe
(involves: C57BL/6J * SJL/J) 		absence seizures J:43429
seizures J:43429
tonic-clonic seizures J:43429
\Slc9a1tm1Smb/\Slc9a1tm1Smb
(involves: 129X1/SvJ * Black Swiss) 		convulsive seizures J:54705
\Slc9a6tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
\Slc10a4tm1Tigm/\Slc10a4tm1Tigm
(involves: 129S/SvEvBrd) 		abnormal spike wave discharge J:196996
increased susceptibility to pharmacologically induced seizures J:196996
seizures J:196996
\Slc12a5tm1Dlp/\Slc12a5+
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:113307
\Slc12a5tm1Dlp/\Slc12a5tm1Dlp
(involves: 129 * C57BL/6J) 		tonic-clonic seizures J:113307
\Slc12a5tm1Hsav/\Slc12a5tm2Hsav
(involves: 129S1/Sv * 129S2/SvPasHsd * 129X1/SvJ * C57BL/6J * C57BL/6JOlaHsd) 		increased susceptibility to pharmacologically induced seizures J:101079
\Slc12a6tm1Tjj/\Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:86183
\Slc13a1tm1Mark/\Slc13a1+
(involves: 129T2/SvEms * C57BL/6J) 		clonic seizures J:86561
\Slc13a1tm1Mark/\Slc13a1tm1Mark
(involves: 129T2/SvEms * C57BL/6J) 		clonic seizures J:86561
\Slc17a5tm1Lex/\Slc17a5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		environmentally induced seizures J:158444
tonic-clonic seizures J:158444
\Slc17a8tm1Edw/\Slc17a8tm1Edw
(involves: 129P2/OlaHsd * C57BL/6) 		nonconvulsive seizures J:132704
\Slc18a3tm1Mca/\Slc18a3tm1Mca
(involves: 129S4/SvJae * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:136620
\Slc25a12Gt(OST123999)Lex/\Slc25a12Gt(OST123999)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		convulsive seizures J:101164
\Slc25a46atc/\Slc25a46atc
(B6.Cg-Slc25a46atc) 		tonic-clonic seizures J:242350
\Slc32a1tm2(cre)Lowl/\Slc32a1tm2(cre)Lowl
(either: B6J.129S6(FVB)-Slc32a1tm2(cre)Lowl or (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)) 		increased kindling response J:308516
tonic-clonic seizures J:308516
\Slc37a4tm1Jyc/\Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6) 		seizures J:86005
\Slitrk3tm1Jaru/\Slitrk3tm1Jaru
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:232385
seizures J:232385
\Smarcb1tm2Sho/\Smarcb1tm2Sho
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA) 		seizures J:226786
\Snap25tm1.1Bark/\Snap25tm1.1Bark
(B6.Cg-Snap25tm1.1Bark) 		seizures J:142096
\Snap25tm1Bark/\Snap25tm1Bark
(B6.Cg-Snap25tm1Bark) 		seizures J:142096
\Snap25tm1Mtaka/\Snap25tm1Mtaka
(B6N.129P2-Snap25tm1Mtaka) 		convulsive seizures J:177870
\Snap25tm2Mcw/\Snap25tm2Mcw
(involves: C57BL/6J) 		myoclonus J:94005
\Snap91tm1.1Tmar/\Snap91tm1.1Tmar
(involves: 129S6/SvEvTac * C57BL/6NTac) 		tonic-clonic seizures J:228428
\Sod2tm1Cje/\Sod2tm1Cje
(involves: C57BL/6J * DBA/2J) 		seizures J:73998, J:98007
\Sox1tm1Vep/\Sox1tm1Vep
(either: (involves: 129/Sv * 129S/SvEv) or (involves: 129S/SvEv * MF1)) 		seizures J:46636
\Sox1tm1Vep/\Sox1tm2Vep
\Sox2tm1Vep/\Sox2+
(involves: 129S/SvEv) 		seizures J:99610
\Sox1tm2Vep/\Sox1tm2Vep
(Not Specified) 		seizures J:99610
\Sox2tm2Skn/\Sox2tm3Skn
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		nonconvulsive seizures J:92063
\Sox10gt/\Sox10gt
(involves: HYIII/LeJ) 		sporadic seizures J:7723
\Sox10gt/\Sox10gt
(involves: C57BL/6 * GT/Le) 		seizures J:216967
\sps/\sps
(involves: C57BL/10Bg) 		convulsive seizures J:12239, J:32781
\Sptbn2Gt(XK442)Byg/\Sptbn2Gt(XK442)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		clonic seizures J:158494
\St3gal4tm1.1Bsi/\St3gal4tm1.1Bsi
(B6J.B6N-St3gal4tm1.1Bsi) 		decreased kindling response J:217104
\Stamtm1Sug/\Stamtm1Sug
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69504
\Stx1btm1.1Sud/\Stx1btm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:138035
\Sult4a1em1Uab/\Sult4a1em1Uab
(C57BL/6J-Sult4a1em1Uab) 		absence seizures J:280143
\Sult4a1em2Uab/\Sult4a1em2Uab
(C57BL/6J-Sult4a1em2Uab) 		absence seizures J:280143
\Sumf1Gt(RST760)Byg/\Sumf1Gt(RST760)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:120146
\Sv2atm1Baj/\Sv2a+
(Not Specified) 		seizures J:59073
\Sv2atm1Baj/\Sv2atm1Baj
(Not Specified) 		seizures J:59073
\Sv2atm1Baj/\Sv2atm1Baj
(involves: 129X1/SvJ * C57BL/6) 		seizures J:70828
\Sv2atm1Baj/\Sv2atm1Baj
\Sv2btm1Baj/\Sv2btm1Baj
(involves: 129 * C57BL/6) 		seizures J:70828
\Sv2atm1Sud/\Sv2atm1Sud
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:59180
\Sv2atm1Sud/\Sv2atm1Sud
\Sv2btm1Sud/\Sv2btm1Sud
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:59180
\Sv2btm1Baj/\Sv2btm1Baj
(involves: 129 * C57BL/6) 		seizures J:70828
\Syn1tm1Pggd/\Syn1tm1Pggd
(involves: 129) 		abnormal seizure response to electrical stimulation J:29086
\Syn1tm1Pggd/\Syn1tm1Pggd
\Syn2tm1Pggd/\Syn2tm1Pggd
\Syn3tm1Pggd/\Syn3tm1Pggd
(involves: 129 * 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:175256
tonic-clonic seizures J:175256
\Syn1tm1Sud/\Syn1tm1Sud
(involves: 129S7/SvEvBrd) 		convulsive seizures J:15701
\Syn1tm1Sud/\Syn1tm1Sud
\Syn2tm1Sud/\Syn2tm1Sud
(involves: 129S7/SvEvBrd) 		convulsive seizures J:26920
\Syn2tm1Pggd/\Syn2tm1Pggd
(Not Specified) 		seizures J:202031
\Syn2tm1Sud/\Syn2tm1Sud
(involves: 129S7/SvEvBrd) 		convulsive seizures J:26920
\Syngap1tm1Rlh/\Syngap1+
(involves: 129S1/Sv * 129X1/SvJ) 		audiogenic seizures J:193208
increased susceptibility to pharmacologically induced seizures J:193208
\Syngr1tm1Sud/\Syngr1tm1Sud
\Syngr3tm1Sud/\Syngr3tm1Sud
\Synprtm1Sud/\Synprtm1Sud
\Syptm1Sud/\Syptm1Sud
(Not Specified) 		seizures J:156812
\Synj1tm1Pdc/\Synj1tm1Pdc
(involves: 129S1/Sv * C57BL/6) 		convulsive seizures J:58087
\Szs1C57BL/6J/\Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
seizures J:38888
\Szs1DBA/2J/\Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
seizures J:38888
\Szs1DBA/2J/\Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
\Szs1DBA/2J/\Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty * C57BL/6J) 		abnormal seizure response to electrical stimulation J:89732
\Szs2C57BL/6J/\Szs2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:38888
\Szs2C57BL/6J/\Szs2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:38888
\Szs5DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
\Szs6C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
\Szs7DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
\Szs8DBA/2J/\Szs8C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
\Szs8DBA/2J/\Szs8DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
\Szs9C57BL/6J/\Szs9DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
\Szs9DBA/2J/\Szs9DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
\Szs10C57BL/6J/\Szs10C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
\Szs10C57BL/6J/\Szs10DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
\Szs11C57BL/6J/\Szs11C57BL/6J
(D2.B6-(D5Mit345-D5Mit403)) 		abnormal seizure response to electrical stimulation J:129499
\Szs11DBA/2J/\Szs11C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
\Szs11DBA/2J/\Szs11DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
\Szs11DBA/2J/\Szs11DBA/2J
(B6.D2-(D5Mit75-D5Mit403)) 		abnormal seizure response to electrical stimulation J:129499
\Szs12DBA/2J/\Szs12C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
\Szs12DBA/2J/\Szs12DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
\Szs13DBA/2J/\Szs13C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
\Szs13DBA/2J/\Szs13DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
\Szt1/\Szt1+
(involves: BALB/cByJ * BALB/cJ * C57BL/6J) 		abnormal seizure response to electrical stimulation J:82964
abnormal seizure response to pharmacological agent J:82964
\Szt1/\Szt1+
(C57BL/6J-Szt1) 		abnormal seizure response to electrical stimulation J:136510
\Szt1/\Szt1+
\Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: C57BL/6J * SJL/J) 		seizures J:136510
tonic-clonic seizures J:136510
\Szt2Gt(XH662)Byg/\Szt2+
(involves: 129P2/OlaHsd * C57BL/6J) 		minimal clonic seizures J:150942
\Szt2Gt(XH662)Byg/\Szt2Gt(XH662)Byg
(129S1.129P2(B6)-Szt2Gt(XH662)Byg/FrkJ) 		maximal tonic hindlimb extension seizures J:150942
minimal clonic seizures J:150942
\Szt2Gt(XH662)Byg/\Szt2m1Frk
(involves: 129P2/OlaHsd * C57BL/6J) 		minimal clonic seizures J:150942
\Szt2m1Frk/\Szt2m1Frk
(C57BL/6J-Szt2m1Frk) 		abnormal kindling response J:150942
minimal clonic seizures J:150942
\Szt2m1Frk/\Szt2m1Frk
(involves: BALB/cByJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:150942
minimal clonic seizures J:150942
tonic-clonic seizures J:150942
\Szv1C57BL/6J/\Szv1C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
\Szv2C57BL/6J/\Szv2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
\Szv2C57BL/6J/\Szv2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
\Szv3C57BL/6J/\Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
\Szv3DBA/2J/\Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
\Tal2tm1Thr/\Tal2tm1Thr
(involves: 129 * C57BL/6) 		convulsive seizures J:65762
\Tbc1d24em2Tbf/\Tbc1d24em2Tbf
(C57BL/6J-Tbc1d24em2Tbf) 		tonic-clonic seizures J:273646
\Tbc1d24em2Tbf/\Tbc1d24em5Tbf
(C57BL/6J-Tbc1d24em2Tbf Tbc1d24em5Tbf) 		seizures J:299025
\Tcf12tm2Zhu/\Tcf12+
(Not Specified) 		seizures J:120411
\Tectatm3.1Gpr/\Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
\Tectatm4.1Gpr/\Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
\Tectatm5.1Gpr/\Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
\Teftm1Schb/\Teftm1Schb
(involves: 129S2/SvPas) 		absence seizures J:90854
seizures J:90854
\Ten1em1(IMPC)Hmgu/\Ten1em1(IMPC)Hmgu
(involves: C57BL/6NCrl) 		seizures J:365069
\Tg(AGT)2-5Afu/0
(involves: C57BL/6) 		convulsive seizures J:130455
\Tg(APPswe,PSEN1dE9)85Dbo/0
(B6.Cg-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax) 		convulsive seizures J:227541
\Tg(APPswe,PSEN1dE9)85Dbo/0
(D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo) 		convulsive seizures J:227541
\Tg(ATN1*)Q129Stsu/0
(involves: 129S/SvEv * C57BL/6J) 		absence seizures J:144379
\Tg(C9orf72)500Lpwr/0
(FVB/NJ-Tg(C9orf72)500Lpwr) 		seizures J:239579
\Tg(CAG-cre/Esr1*)5Amc/0
\Ube3atm1Yelg/\Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl * C57BL/6J) 		audiogenic seizures J:222400
\Tg(Camk2a-Bdnf)A9Stl/0
(C57BL/6-Tg(Camk2a-Bdnf)A9Stl/J) 		psychomotor seizures J:216846
seizures J:216846
\Tg(Camk2a-Crem)I15Endo/0
(involves: C3H * C57BL/6) 		abnormal kindling response J:137666
\Tg(Camk2a-Crem)IIEndo/0
(C57BL/6-Tg(Camk2a-Crem)IIEndo/EndoRbrc) 		abnormal kindling response J:137666
\Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal kindling response J:59490
abnormal seizure response to electrical stimulation J:59490
increased susceptibility to pharmacologically induced seizures J:59490
tonic seizures J:59490
\Tg(Camk2a-tTA)1Mmay/0
\Tg(tetO-MAPT)32Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT)32Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
\Tg(Camk2a-tTA)1Mmay/0
\Tg(tetO-MAPT*A152T)L1Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT*A152T)L1Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
\Tg(Camk2a-tTA)1Mmay/0
\Tg(tetO-Mtor*)#Atai/0
(involves: C57BL/6 * DBA/2 * ICR) 		seizures J:211789
\Tg(Cnp-Gpr17)1Qrlu/0
(Not Specified) 		seizures J:154602
\Tg(DBH-Gal)1923Stei/0
(B6.Cg-Tg(DBH-Gal)1923Stei) 		decreased susceptibility to pharmacologically induced seizures J:77625
seizures J:77625
\Tg(Eno2-PTGS2)32Pasi/0
(involves: C3H/HeNTac * C57BL/6NTac) 		seizures J:100973
tonic-clonic seizures J:100973
\Tg(Eno2-Scn2a1*)Q54Mm/0
(B6.Cg-Tg(Eno2-Scn2a1*)Q54Mm) 		convulsive seizures J:170734
seizures J:136510
\Tg(GFAP-cre)8Gtm/0
\Tsc2tm1.1Mjg/\Tsc2tm1.1Mjg
(involves: 129X1/SvJ * 129S1/Sv * C57BL/6 * CBA) 		seizures J:167241
\Tg(GFAP-EFNA3)181Kln/0
(involves: C57BL/6 * FVB) 		increased susceptibility to pharmacologically induced seizures J:154648
\Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
\Tg(Gfap-Ifna1)12Ilc/0
(involves: BALB/c * C57BL/6J) 		seizures J:68811
\Tg(Gfap-Ifna1)39Ilc/0
(involves: BALB/c * C57BL/6J) 		seizures J:68811
\Tg(Gfap-Il6)G16Lms/0
\Tg(Gfap-lacZ)1Lms/0
(involves: C57BL/6J * SJL) 		seizures J:125549
\Tg(Gfap-Il6)G167Lms/0
(involves: C57BL/6J * SJL) 		seizures J:125549
\Tg(Gfap-Il6)G167Lms/\Tg(Gfap-Il6)G167Lms
(involves: C57BL/6J * SJL) 		seizures J:125549
\Tg(Gfap-Il6)G369Lms/0
(involves: C57BL/6J * SJL) 		seizures J:125549
\Tg(Gfap-TGFB1)64Lms/\Tg(Gfap-TGFB1)64Lms
(involves: BALB/c * SJL) 		seizures J:27781
\Tg(HDexon1)62Gpb/0
(involves: C57BL/6J * CBA/J) 		seizures J:36689
\Tg(Lgi1*)#Mpan/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:154129
\Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J) 		abnormal spike wave discharge J:197168
clonic seizures J:197168
increased susceptibility to pharmacologically induced seizures J:197168
seizures J:197168
\Tg(Mbp-Pad2)28Fgm/0
(involves: CD-1) 		convulsive seizures J:142650
\Tg(Mbp-Pad2)28Fgm/\Tg(Mbp-Pad2)28Fgm
(involves: CD-1) 		convulsive seizures J:142650
\Tg(Mbp-SNCA)29Ema/0
(involves: C57BL/6 * DBA/2) 		seizures J:102867
\Tg(MECP2)1Hzo/0
(involves: FVB) 		clonic seizures J:94407
\Tg(Mov1/Tyr)OVE876BPay/Y
(FVB/N-Tg(Mov1/Tyr)OVE876BPay) 		audiogenic seizures J:167614
\Tg(Mov1/Tyr)OVE876BPay/\Tg(Mov1/Tyr)OVE876BPay
(FVB/N-Tg(Mov1/Tyr)OVE876BPay) 		audiogenic seizures J:167614
\Tg(Nes-cre)1Kln/0
\Ube4bem1Bcgen/\Ube4bem1Bcgen
(involves: C57BL/6N * SJL) 		tonic-clonic seizures J:332423
\Tg(Pcp2-cre)2Mpin/0
\Tsc2tm1.1Mjg/\Tsc2tm1.2Mjg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:174327
\Tg(PLP1*)4Rsj/0
(involves: CD-1) 		environmentally induced seizures J:24069
\Tg(Plp1-HTT*150Q)4aXjl/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:221608
\Tg(Plp1-Lmnb1)#Yfu/0
(involves: FVB) 		seizures J:197168
\Tg(Plp)66Kan/0
\Tg(Plp)72Kan/0
(involves: C57BL/6 * DBA) 		convulsive seizures J:17373
\Tg(Plp)66Kan/\Tg(Plp)66Kan
(involves: C57BL * DBA) 		seizures J:17373
\Tg(Plp)66Kan/\Tg(Plp)66Kan
(B6NCrl.Cg-Tg(Plp)66Kan) 		seizures J:156106
\Tg(Prnp*)#Rgab/0
(involves: C57BL/6 * FVB/N) 		myoclonus J:183170
\Tg(Prnp-ATN1)150Dbo/?
(involves: C3H * C57BL/6) 		seizures J:70362
\Tg(Prnp-ATXN3)BVcg/\Tg(Prnp-ATXN3)BVcg
(involves: C3H/HeJ * C57BL/6) 		seizures J:96574
\Tg(Prnp-ATXN3)CVcg/\Tg(Prnp-ATXN3)CVcg
(involves: C3H/HeJ * C57BL/6) 		seizures J:96574
\Tg(Prnp-lacZ/ATXN10*)#Teas/0
(involves: FVB/N) 		increased susceptibility to pharmacologically induced seizures J:222081
\Tg(Prnp-MAPT*)2652Gds/\Tg(Prnp-MAPT*)2652Gds
(B6.Cg-Tg(Prnp-MAPT*)2652Gds) 		seizures J:244052
\Tg(Prnp-TBP*)71-16Xjl/0
(FVB/N-Tg(Prnp-TBP*)71-16Xjl) 		sporadic seizures J:130775
\Tg(Prnp-TBP*)71-27Xjl/0
(FVB/N-Tg(Prnp-TBP*)71-27Xjl) 		sporadic seizures J:130775
\Tg(Prnp-TBP*)105Xjl/0
(FVB/N-Tg(Prnp-TBP*)105Xjl) 		sporadic seizures J:130775
\Tg(Prnp-tTA)F959Sbp/0
\Tg(tetO-Chrnb2*V287L)H3Gica/0
(involves: 129S7/SvEvBrd * FVB) 		seizures J:145855
\Tg(Prnp-tTA)F959Sbp/?
\Tg(TetO-Nfkbia*S32A*S36A)1Wcg/?
(involves: 129S7/SvEvBrd * DBA * FVB/N) 		environmentally induced seizures J:112973
\Tg(RP23-65I14)1Jno/?
(involves: FVB) 		absence seizures J:146431
\Tg(RP23-65I14)2Jno/?
(involves: FVB/N) 		absence seizures J:146431
\Tg(Scn1a*)RH9Aesc/0
(involves: FVB/NJ) 		increased susceptibility to pharmacologically induced seizures J:150454
\Tg(Shank3-EGFP)1Hzo/0
(involves: FVB/N) 		seizures J:201867
\Tg(Tek-tTA)1Rwng/0
\Tg(tetO-Notch4*)1Rwng/0
(involves: FVB/N) 		seizures J:139943
\Tg(Thy1-APP)4Vln/0
(involves: FVB/N) 		seizures J:53800
\Tg(Thy1-App*R609D*K612E)2Vln/0
(involves: C57BL * CBA/J) 		seizures J:32213
\Tg(Thy1-App*R609D*K612E)4Vln/0
(involves: FVB) 		clonic seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
\Tg(Thy1-App*R609D*K612E)4Vln/\Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB) 		clonic seizures J:32213
decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
\Tg(Thy1-App*R609D*K612E)6Vln/0
(involves: FVB) 		clonic seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
\Tg(Thy1-App*R609D*K612E)6Vln/\Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB) 		clonic seizures J:32213
decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
\Tg(Thy1-APPLon)2Vln/0
(involves: FVB/N) 		seizures J:53800
\Tg(Thy1-APPSw)1Vln/0
(involves: FVB/N) 		seizures J:53800
\Tg(Thy1-MAPT*)1Avil/\Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA) 		increased susceptibility to pharmacologically induced seizures J:201700
myoclonus J:201700
nonconvulsive seizures J:201700
seizures J:201700
tonic-clonic seizures J:201700
\Tg(Thy1-SERPINI1*G392E)333Icka/0
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
\Tg(Thy1-SERPINI1*G392E)333Icka/\Tg(Thy1-SERPINI1*G392E)333Icka
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
\Tg(Tk1-DPP4)27Ysj/0
(involves: C57BL/6 * FVB/N) 		convulsive seizures J:290259
\Tg(UBC-Adk)1Bois/0
(B6;129P3-Adktm1Bois Tg(UBC-Adk)1Bois) 		abnormal seizure response to pharmacological agent J:105483
nonconvulsive seizures J:105483
\Thrbtm1Df/\Thrbtm1Df
(either: B6.129S1-Thrbtm1Df or (involves: 129S1/Sv * C57BL/6J)) 		audiogenic seizures J:103702
\Tinf2tm2.2Tdl/\Tinf2+
(involves: BALB/cJ * C57BL/6) 		seizures J:207367
\Tmem151bnmf389/\Tmem151b+
(B6N.B6J-Tmem151bnmf389/FrkJ) 		abnormal seizure response to electrical stimulation J:362012
\Tmem151bnmf389/\Tmem151bnmf389
(B6N.B6J-Tmem151bnmf389/FrkJ) 		abnormal seizure response to electrical stimulation J:362012
increased kindling response J:362012
maximal tonic hindlimb extension seizures J:362012
seizures J:362012
tonic-clonic seizures J:362012
\Tmem151bnmf389/\Tmem151bnmf389
(C57BL/6J-Tmem151bnmf389/J) 		abnormal seizure response to electrical stimulation J:362012
increased kindling response J:362012
maximal tonic hindlimb extension seizures J:362012
seizures J:362012
tonic-clonic seizures J:362012
\Tmem151btm1b(KOMP)Wtsi/\Tmem151bnmf389
(B6N.Cg-Tmem151btm1b(KOMP)Wtsi/Tmem151bnmf389/Frk) 		abnormal seizure response to electrical stimulation J:362012
increased kindling response J:362012
\Tmem151btm1b(KOMP)Wtsi/\Tmem151btm1b(KOMP)Wtsi
(C57BL/6N-Tmem151btm1b(KOMP)Wtsi/J) 		abnormal seizure response to electrical stimulation J:362012
increased kindling response J:362012
\tmgc61/\tmgc61
(Mixed stock) 		decreased susceptibility to pharmacologically induced seizures J:92490
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx
\Tnfrsf1btm1Imx/\Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		seizures J:112713
\Tpp1tm1Dgen/\Tpp1tm1Dgen
(involves: 129S1/Sv * C57BL/6) 		seizures J:101679
\Tpp1tm1Plob/\Tpp1tm1Plob
(involves: 129S1/Sv * C57BL/6) 		audiogenic seizures J:94884
\Tppptm1.1(KOMP)Vlcg/\Tppptm1.1(KOMP)Vlcg
(C57BL/6N-Tppptm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
\Trim2Gt(IRESBetageo)11Pgr/\Trim2Gt(IRESBetageo)11Pgr
(involves: 129/Sv * C57BL/6) 		seizures J:140337
\Trim3tm1Mak/\Trim3tm1Mak
(B6.129P2-Trim3tm1Mak) 		decreased susceptibility to pharmacologically induced seizures J:161372
\Trp53tm1Elee/\Trp53tm1Elee
\Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJae * FVB/N) 		seizures J:149662
\Trp53tm1Elee/\Trp53tm1Tyj
\Tg(GFAP-cre)25Mes/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		seizures J:149662
\Trpc5tm1.1Lbi/Y
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
\Trpc5tm1.1Lbi/\Trpc5tm1.1Lbi
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
\Trpm7tm1Agry/\Trpm7+
(involves: 129) 		seizures J:205665
\Tsc1tm1Djk/\Tsc1tm1.1Djk
\Tg(Syn1-cre)671Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		seizures J:121858
sporadic seizures J:121858
\Tsc1tm1Djk/\Tsc1tm1Djk
\Tg(GFAP-cre)8Gtm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		seizures J:116872, J:167241
\Tsc1tm1Djk/\Tsc1tm1Djk
\Tg(GFAP-cre)#Gtm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		seizures J:176586
\Tsc2tm1.1Kcess/\Tsc2tm1.1Kcess
\Emx1tm1(cre)Krj/\Emx1+
(involves: 129S/Sv * C57BL/6J) 		environmentally induced seizures J:195049
\tsl/\tsl
(CByJNarl(B6NTacTcu)-tsl) 		seizures J:275934
\Ttll1tm1Seto/\Ttll1+
\Ttll7tm1Seto/\Ttll7tm1Seto
(involves: 129 * 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:345300
\Tubg1tm2.1Ics/\Tubg1+
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:275532
\Ty/Y
((129P3/J x NZB/BlNJ)F1) 		seizures J:13773
\Tyl/Y
(involves: A/J * C57BL/6J) 		seizures J:14294
\Tyro3tm1Grl/\Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal seizure response to inducing agent J:54681
\Ube3atm1Alb/\Ube3a+
(involves: 129S7/SvEvBrd * C57BL/6) 		absence seizures J:50811
audiogenic seizures J:50811
tonic-clonic seizures J:50811
\Ube3atm1Alb/\Ube3a+
(involves: 129S7/SvEvBrd) 		audiogenic seizures J:50811
tonic-clonic seizures J:50811
\Ube3atm1Alb/\Ube3atm1Alb
(involves: 129S7/SvEvBrd * C57BL/6) 		audiogenic seizures J:50811
\Ube3atm1Alb/\Ube3atm1Alb
(involves: 129S7/SvEvBrd) 		audiogenic seizures J:50811
\Ube3atm1Jwf/\Ube3a+
(B6.129S4-Ube3atm1Jwf) 		abnormal spike wave discharge J:102546, J:75622, J:95305
\Ube3atm1Yelg/\Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl) 		audiogenic seizures J:222400
\Ugt1tm1.1Afmu/\Ugt1tm1.1Afmu
(FVB.Cg-Ugt1tm1.1Afmu) 		seizures J:216224
\Unc13btm2Bros/\Unc13btm2Bros
(Not Specified) 		sporadic seizures J:77339
\Usf1tm1Msw/\Usf1tm1Msw
(involves: 129S7/SvEvBrd * C57BL/6) 		environmentally induced seizures J:46788
sporadic seizures J:46788
\Usf2tm1Msw/\Usf2tm1Msw
(involves: 129S7/SvEvBrd * C57BL/6) 		sporadic seizures J:46788
\Usp18tm1Dez/\Usp18tm1Dez
(involves: 129S1/Sv * 129X1/SvJ) 		convulsive seizures J:78821
\Vcptm1Itl/\Vcp+
(B6.129S-Vcptm1Itl) 		seizures J:166230
tonic-clonic seizures J:166230
\Wwoxem1Mald/\Wwoxem1Mald
(FVB/N-Wwoxem1Mald) 		convulsive seizures J:339564
tonic-clonic seizures J:339564
\Xrcc1tm1Pmc/\Xrcc1tm1Pmc
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		seizures J:152528
\Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to pharmacologically induced seizures J:121330
\Zfp14tm1b(KOMP)Wtsi/\Zfp14tm1b(KOMP)Wtsi
(C57BL/6N-Zfp14tm1b(KOMP)Wtsi/J) 		convulsive seizures J:211773
\Zfp24hmcns-2J/\Zfp24hmcns-2J
(CByJ(Cg)-Zfp24hmcns-2J/GrsrJ) 		tonic seizures J:202595
\Zfp24hmcns/\Zfp24hmcns
(C3.Cg-a Zfp24hmcns/GrsrJ) 		tonic seizures J:156938
\Zfp24tm1.1Pop/\Zfp24tm1.1Pop
\Cnptm1(cre)Kan/\Cnp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		tonic seizures J:156938
\Zfp24tm1.2Pop/\Zfp24tm1.2Pop
(involves: 129S4/SvJae * C57BL/6) 		tonic seizures J:156938
\Zfp597tm1Hnawa/\Zfp597+
(B6.Cg-Zfp597tm1Hnawa) 		seizures J:278329
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory